February 16, 2010
Solvay closes EUR 5.2 billion sale of Solvay Pharmaceuticals to Abbott
Solvay books net capital gain of EUR 1.7 billion on transaction [EN]-[FR]-[NL]
February 16, 2010
Solvay launches investment program in Solvay treasury shares [EN]-[FR]-[NL]
February 11, 2010
Solvay launches three Research, Development & Technology centers in Asia
RD&T Centers in India, Korea and China will strengthen Solvay’s presence and support innovation in this growing region
[EN]-[FR]-[NL]
February 10, 2010
Solvay will build a very large fuel cell at SolVin’s Antwerp plant
More than EUR 5 million invested in Proton Exchange Membrane Fuel Cell on hydrogen [EN]-[FR]-[NL]
January 07, 2010
Vinythai prepares construction of its Epichlorohydrin plant in Thailand
Solvay’s Thai affiliate to invest EUR 160 million using Solvay’s innovative Epicerol® technology [EN]-[FR]-[NL]
January 05, 2010
New Year's address by Mr Christian Jourquin, Chairman of the Executive Committee, to the employees of the Solvay Group
The strength to change in order to shape our future [EN]-[FR]-[NL]
December 15, 2009
Solvay celebrates breakthrough products and technologies for its sustainable and profitable growth in its Innovation Trophy 2009
Solvay Group distinguished ten innovations during the Solvay Innovation Trophy ceremony yesterday at Solvay’s headquarters in Brussels, Belgium. [EN]-[FR]-[NL]
December 11, 2009
Solvay launches tender offer on shares Vinythai
Offer will allow Solvay to support development of Vinythai’s businesses [EN]-[FR]-[NL]
December 10, 2009
Solvay supports Solar Impulse’s takeoff with innovative materials and knowhow
First solar-powered airplane contains 11 Solvay products [EN]-[FR]-[NL]
December 01, 2009
Solvay inaugurates production unit in Korea for a new additive for Lithium ion batteries
New Monofluoroethylene Carbonate plant to serve growing market in Far East [EN]-[FR]-[NL]
November 10, 2009
Solvay creates shared services center in Brazil for its affiliates in the Americas
New unit in Curitiba to improve competitiveness of Solvay Group [EN]-[FR]-[NL]
November 04, 2009
Inergy Automotive Systems starts producing fuel systems in its new plant in Stavrovo, Russia
The Solvay and Plastic Omnium joint venture serves Russian automotive market [EN]-[FR]-[NL]
October 29, 2009
Nine months 2009 results
Operating result in the third quarter (EUR 285 million) in line with last year’s (-2%) and improved compared to the two preceding quarters [EN]-[FR]-[NL]
October 28, 2009
Solvay increases sodium bicarbonate production in Italy to serve growing demand
New Sodium Bicarbonate capacity will mainly be used for environmental applications [EN]-[FR]-[NL]
October 08, 2009
Solvay and Huatai to jointly build hydrogen peroxide plant in China
Hydrogen Peroxide plant will produce for growing Chinese market [EN]-[FR]-[NL]
September 28, 2009
Solvay opts for strategic refocus of activities
Decision to sell Pharmaceuticals Sector to Abbott [EN]-[FR]-[NL]
September 09, 2009
Solvay’s cell-based production facility for Influenza vaccines validated and operational
Solvay today announces that its affiliate Solvay Biologicals has completed the validation for its cell-based production facility following a successful inspection by the Dutch authorities. [EN]-[FR]-[NL]
September 08, 2009
Solvay signs agreement to acquire majority in Berezniki soda ash plant in Russia
Solvay pursues geographical expansion strategy in markets with growth potential [EN]-[FR]-[NL]
August 27, 2009
Solvay’s new PVDF significantly increase power capacity lithium-ion batteries
Innovative new PVDF grades bring SOLVAY an innovative actor in the Li ion batteries for hybrid and electric cars [EN]-[FR]-[NL]
August 20, 2009
Solvay increases investment in innovative printed electronics by raising its participation in Plextronics
Investment in radical innovation in organic electronics and sustainable energy [EN]-[FR]-[NL]
July 30, 2009
First half 2009 results
Good resilience in second quarter operating result (EUR 164 million), up from the first quarter (EUR 142 million)
[EN]-[FR]-[NL]
July 23, 2009
Solvay establishes Solvay Energy to manage energy purchases
New subsidiary will optimize net energy costs of Solvay Group [EN]-[FR]-[NL]
July 17, 2009
Unimed Pharmaceuticals, LLC, decides not to file a patent infringement suit at this time against Perrigo Israel Pharmaceuticals, LTD. following the receipt of a paragraph IV certification for a generic formulation of Androgel® 1%
The low volume formulation of AndroGel, for which an NDA was submitted to FDA in the first quarter of 2009, is not within the scope of Perrigo’s ANDA. [EN]-[FR]-[NL]
July 16, 2009
The analysis of the various strategic options for Solvay's pharmaceutical activities is continuing [EN]-[FR]-[NL]
June 30, 2009
Solvay is aboard the Solar Impulse
Solvay’s know how, innovative solutions and ultrahigh-performance polymers are contributing to the Solar Impulse airplane [EN]-[FR]-[NL]
June 25, 2009
Inergy Automotive Systems brings two innovations which are reducing environmental impact of cars
The Solvay and Plastic Omnium joint venture innovates with SCR system which strongly reduces concentration of nitrogen oxides in diesel exhaust gasses,... [EN]-[FR]-[NL]
June 18, 2009
Inergy Automotive Systems is building new factories in China and India to serve growing automotive markets
The Solvay and Plastic Omnium joint venture reinforces its presence at the heart of the fast-growing automotive industry in Asia [EN]-[FR]-[NL]
June 10, 2009
Solvay Pharmaceuticals Inc. has been informed of ANDA filing for generic Androgel® in the USA
Attempt to seek approval for a generic version of Androgel® (testosterone gel) 1% CIII [EN]-[FR]-[NL]
June 04, 2009
Solvay Indupa successfully completes upgrade and expansion of its vinyl activities in Brazil
Solvay strengthens competitiveness of its PVC plant at Santo André, Brazil [EN]-[FR]-[NL]
May 20, 2009
Solvay will early close its public offering of a 6 year bond for a total amount of EUR 500 million
Solvay S.A. announces today that it will early close on Wednesday 20 may at the end of the business day its 6 year bond issue for a total amount of EUR 500 million. [EN]-[FR]-[NL]
May 15, 2009
Public offering of a 6 year bond bearing interest at 5.0 % issued by Solvay S.A. for an expected amount of minimum EUR 150 million
The Solvay Group announces today that it will issue through Solvay S.A. a 6 year bond for a minimum total amount of EUR 150 million in the form of a public offering in Belgium and Luxembourg. The bonds will bear interest at an annual gross rate of 5.0%. [EN]-[FR]-[NL]
May 12, 2009
Annual Shareholders Meeting 2009
Speeches by the Chairmen - Discours des Présidents - Toespraken van de Voorzitters [EN]-[FR]-[NL]
May 12, 2009
First quarter 2009 results
Good resilience of operating result (EUR 142 million) in the first quarter, up from the fourth quarter of 2008 (EUR 125 million). Due to the global crisis, a decrease compared to the high result of the first quarter of 2008 (EUR 300 million) [EN]-[FR]-[NL]
May 11, 2009
Electrolysis: Solvay licenses out energy saving technology to Uhde
Solvay-patented processes for brine treatment increases membrane life and cuts effluents of new plants [EN]-[FR]-[NL]
April 22, 2009
Note about the press release published on April 1st
Solvay confirms it is proceeding with an analysis of various options for its pharmaceutical activities. [EN]-[FR]-[NL]
April 14, 2009
Ms. Petra Mateos-Aparicio Morales and Mr. Hervé Coppens d’Eeckenbrugge are proposed to join Solvay’s Board of Directors [EN]-[FR]-[NL]
April 09, 2009
Chairmen's statement
"Managing Challenges" [EN]-[FR]-[NL]
April 01, 2009
Solvay confirms it is proceeding with an analysis of various options for its pharmaceutical activities
Solvay Group wishes to react to the rumours reported today in a press article. [EN]-[FR]-[NL]
March 10, 2009
Solvay announces the startup of SolVin’s new production capacity for Diofan® PVDC latex at its Tavaux plant
Construction completed ahead of schedule to serve food & pharmaceutical packaging industrie [EN]-[FR]-[NL]
February 19, 2009
2008 Results
2008 operating result (EUR 965 million) down by 19% compared to the record result of 2007. Fourth quarter affected by economic crisis and inventory depreciation. [EN]-[FR]-[NL]
December 16, 2008
Solvay welcomes FDA approval for Trilipix™ (fenofibric acid)
New therapy in combination with a statin helped patients improve HDL and LDL cholesterol and triglycerides in clinical studies [EN]-[FR]-[NL]
December 03, 2008
Solvay takes stake in fuel cell developer ACAL Energy
Investment in innovative low-cost and high reliability fuel cell technology [EN]-[FR]-[NL]
December 02, 2008
Solvay succesfully completes pre-registration of 400 substances in accordance with the REACH regulation (EC) no 1907/2006
Pre-registration is first main step in Solvay’s commitment to fulfill REACH obligations for its products [EN]-[FR]-[NL]
November 27, 2008
Solvay’s management and European Works Council are committing to sustainable development and corporate social responsibility
The CEO and the European Works Council sign a unique charter [EN]-[FR]-[NL]
November 17, 2008
Solvay Pharmaceuticals discontinues R&D activities of its anti-obesity compound SLV319
Solvay Pharmaceuticals announced today its decision to discontinue all R&D activities for its investigational compound SLV319. [EN]-[FR]-[NL]
November 13, 2008
Solvay Group holds 95.33% of Innogenetics shares
Solvay will proceed with squeeze-out of remaining Innogenetics shares and request delisting. [EN]-[FR]-[NL]
October 30, 2008
Nine months 2008 results
Operating results for Solvay Group (EUR 840 million) down by 9% compared to the excellent results of the first nine months 2007. Good resistance in the third quarter (-6%) [EN]-[FR]-[NL]
October 17, 2008
Solvay acquires Alexandria Sodium Carbonate company in Egypt
Expansion into growing Egyptian, Middle Eastern and North-African markets [EN]-[FR]-[NL]
October 15, 2008
Solvay sets ambitious goals for its Sustainable Development
Quantified Targets to Curb the Environmental Impact of the Group’s Activities and Products [EN]-[FR]-[NL]
October 15, 2008
Solvay Group holds 93.1% of Innogenetics
Offer on Innogenetics shares is extended from 22 October to 12 November [EN]-[FR]-[NL]
October 06, 2008
Solvay CEO Christian Jourquin elected President of Cefic
"The Chemical Industry: a Solution Provider" [EN]-[FR]-[NL]
October 01, 2008
Solvay Investors Day
Presentations [EN]
September 29, 2008
Solvay invests EUR 55 milion in reduced electricity consumption and lower environmental impact of its electrolytic unit at Tavaux (F)
Launch of membrane-based electrolytic technology [EN]-[FR]-[NL]
September 25, 2008
Solvay Solexis enters joint development agreement with Strategic Polymer Sciences to develop ultra-high-energy density capacitator materials
New materials increase efficiency of energy storage and medical therapeutics [EN]-[FR]-[NL]
September 24, 2008
Solvay strengthens position in fluorinated high-performance materials in Asia
Second world-class production plant of Polytetrafluoroethylene Micronised Powder [EN]-[FR]-[NL]
September 11, 2008
Vinythai : Solvay’s vinyls affiliate in Thailand increases PVC production capacity
Vinythai strengthens its position as a fully integrated world class PVC producer [EN]-[FR]-[NL]
September 09, 2008
Solvay Pharmaceuticals acquires Innogenetics
Solvay Group holds 84.3% of Innogenetics shares [EN]-[FR]-[NL]
September 04, 2008
Solvay Indupa secures competitive & reliable energy sourcing in Argentina
Alliance with Energy Group Albanesi for the Construction of a New Power Plant [EN]-[FR]-[NL]
August 13, 2008
Umicore and Solvay foster zero emission car racing team
Two established Belgian names sponsor Belgian fuel cell powered racing kart [EN]-[FR]-[NL]
July 31, 2008
First half 2008 results
Operating results for the Solvay Group for the 1st half of 2008: -11% compared to the high level of the 1st half of 2007 - Sustained level of activities - increased energy and raw materials costs [EN]-[FR]-[NL]
July 24, 2008
Solvay Pharmaceuticals S.A. plans the offer period for Innogenetics from August 12 to September 5, 2008
Solvay Pharmaceuticals S.A., a subsidiary of Solvay, the chemical and pharmaceutical group, today announced that it plans the offer period to acquire Innogenetics N.V., a Belgian-based biotechnological company, from August 12 to September 5, pending approval of the takeover prospectus by Belgium’s Banking, Finance and Insurance Commission (CBFA). [EN]-[FR]-[NL]
July 09, 2008
Solvay Pharmaceuticals S.A. increases to eur 6.50 per share its initial tender offer to acquire Innogenetics
Solvay Pharmaceuticals S.A., a subsidiary of Solvay, the chemical and pharmaceutical group, today announced that it will increase its initial conditional tender offer to acquire Innogenetics N.V., a Belgian-based biotechnological company, in a cash transaction valued at EUR 6.50 per share. [EN]-[FR]-[NL]
June 26, 2008
Inergy Automotive Systems starts operations in China
The Solvay / Plastic Omnium joint venture at the heart of a fast-growing industry
[EN]-[FR]-[NL]
June 19, 2008
Solvay's Tavaux (France) Plant to be powered with biomass-based energy
A sustainable and competitive alternative to fossil fuels [EN]-[FR]-[NL]
June 02, 2008
Phase III study of investigational TRILIPIX™ (SLV348/ABT-335), in combination with Astrazeneca’s CRESTOR® meets primary endpoints on key lipids
TriLipix™ in combination with Crestor® improved LDL, HDL and Triglycerides and had reported safety consistent with monotherapies
[EN]-[FR]-[NL]
May 21, 2008
Solvay joins Capricorn‘Cleantech’venture capital fund
Exploring new business developments in sustainable technologies [EN]-[FR]-[NL]
May 14, 2008
Solvay launches new product for air pollution control
Investing USD 40 Million in Innovative Technology to Manufacture SOLVAir ® Select 300 for Flue Gas Treatment [EN]-[FR]-[NL]
May 13, 2008
First quarter 2008 results
Operating results for the Solvay Group in the 1st quarter of 2008 : -8% compared to the high level of the 1st quarter of 2007. An increase of 12% compared to the 4th quarter of 2007. Net income of the Group (eur 220 million) up by 1%. [EN]-[FR]-[NL]
May 13, 2008
Annual Shareholders Meeting 2008
Speeches by the Chairmen - Toespraken van de Voorzitters - Discours des Présidents [EN]-[FR]-[NL]
May 08, 2008
Solvay to power its Bernburg (Germany) plant with secondary solid fuels
Energy generated from Refuse Derived Fuel Available in 2010 [EN]-[FR]-[NL]
April 25, 2008
SOLVAY PHARMACEUTICALS S.A. LAUNCHES FRIENDLY BID TO ACQUIRE INNOGENETICS
Building on a successful R&D co-operation [EN]-[FR]-[NL]
March 31, 2008
Phase III studies of investigational Trilipix™ (SLV348/ABT-335), in combination with statins, meets primary endpoints on improving LDL, triglycerides and HDL
TriLipix™ in combination with statins improved all three key lipids and had reported safety consistent
with TriLipix™ or statin monotherapies
[EN]-[FR]-[NL]
March 12, 2008
FDA approval of Abbott's SIMCOR® marks start of co-promotion with Solvay
FDA Decision Triggers Milestone Payment of USD 100 million by Solvay to Abbott [EN]-[FR]-[NL]
March 06, 2008
Solvay finalized sale of polypropelene compounding activity to Lyondellbasell
Solvay announces today that it has finalized the sale of 100% of its subsidiary Solvay Engineered Polymers (SEP), a major supplier of polypropylene compounds, to LyondellBasell Industries. [EN]-[FR]-[NL]
March 03, 2008
Fournier Laboratories Ireland Ltd and Laboratoires Fournier SA filed patent infringement actions against Teva in the USA
Fournier Laboratories asserts intellectual property of TriCor® (fenofibrate) 145mg NFE [EN]-[FR]-[NL]
February 29, 2008
Solvay Pharmaceuticals S.A. acknowledges decision of Wyeth Pharmaceuticals to terminate the collaboration agreement on bifeprunox
Solvay Pharmaceuticals will evaluate all options for the future of the compound [EN]-[FR]-[NL]
February 15, 2008
2007 Results
Record operating results for Solvay in 2007 of EUR 1.2 billion, up 9% from 2006 [EN]-[FR]-[NL]
February 01, 2008
Sale of Solvay’s Caprolactones business to Perstorp confirmed
Transaction Received European Commission Antitrust Clearance [EN]-[FR]-[NL]
January 23, 2008
Fournier Laboratories Ireland Ltd was informed of anda filing for generic Tricor® in the USA
An Attempt to Seek Approval for a Generic Version of TriCor® 145mg NFE Tablets [EN]-[FR]-[NL]
December 14, 2007
Solvay Indupa will produce bioethanol-based vinyl in Brasil & considers state-of-the-art power generation in Argentina
Polyvinyl chloride (PVC) Derived from Sugar Cane and Salt [EN]-[FR]-[NL]
November 30, 2007
Solvay Science for Innovation Conference focuses on the creation of novel, complex materials
Nobel Prize Winners Lehn and Laughlin Address Solvay Researchers [EN]-[FR]-[NL]
November 29, 2007
Solvay signs agreement to sell polypropylene compounding activity to Basell
Focusing on activities where the Group has better opportunities to create business value [EN]-[FR]-[NL]
November 07, 2007
New clinical data show Solvay’s fenofibrate cuts risk of main causes of vision loss in patients with type 2 diabetes
Fenofibrate offers opportunity to protect patients from most serious consequences of type 2 diabete [EN]-[FR]-[NL]
October 30, 2007
SolVin Awards acclaim vinyl innovators at K2007 for environmental, design and safety achievements
The winners of the 2007 SolVin Awards for PVC Innovation were unveiled yesterday during the K2007 International Plastics Trade Fair in Düsseldorf, Germany, honouring the most impressive innovators among 107 contestants which represented the entire vinyl value chain. [EN]
October 29, 2007
Solvay takes steps to resume growth and restore competitiveness of its Fluor Chemicals business
Focusing on high value added specialties, downsizing production of commodities [EN]-[FR]-[NL]
October 26, 2007
Nine months 2007 results
Solvay’s operating results (EUR 925 million) 5% above the excellent results from the first 9 months of 2006 (+8% in the 3rd quarter) [EN]-[FR]-[NL]
October 24, 2007
Solvay Unveils 'More Plastics with More Performance' at K2007 International Plastics Trade Fair
Solvay announces today that it has unveiled a number of innovative products at a press conference on the opening of the K2007 International Plastics Trade Fair in Düsseldorf, Germany, including the new family of SolvivaTM Biomaterials available for use in implantable medical devices as well as extensions to its Hyflon® and Tecnoflon® fluoropolymers ranges. [EN]-[FR]-[NL]
October 22, 2007
Abbott and Solvay Pharmaceuticals to co-promote Abbott's SIMCOR® in the United States
Solvay Pharmaceuticals has entered into an agreement granting Solvay select co-promotion rights in the United States for Abbott's investigational fixed-dose combination lipid therapy, SIMCOR® (Niaspan®/simvastatin), currently awaiting U.S. Food and Drug Administration (FDA) approval. [EN]-[FR]-[NL]
October 17, 2007
Pipelife starts up production in new russian factory
Solvay Affiliate Expands into One of Europe’s Fastest Growing Markets [EN]-[FR]-[NL]
October 15, 2007
Solvay signs agreement to sell Caprolactones business to Perstorp
Focusing on activities where the Group has maximum control over raw materials [EN]-[FR]-[NL]
October 08, 2007
China : Solvay reinforces its presence and plans for more investments in specialty polymers
PTFE Micronized Powder facility confirmed; more projects under consideration [EN]-[FR]-[NL]
September 26, 2007
Solvay Investors Day
Presentations [EN]
September 24, 2007
Solvin to expand PVDC latex production in world-class plant of Tavaux (France)
A timely, competitive response to serve growing demand from food & pharma industry [EN]-[FR]-[NL]
September 06, 2007
Solvay to build world-class Epicerol® plant in Thailand
Innovative green chemistry technology to serve strong demand for epichlorohydrin [EN]-[FR]-[NL]
August 30, 2007
Solvay expands printed electronics development platform with investment in Plextronics
Innovative Technology for Mass-Production of Displays, Lighting, Solar Cells and ‘Smart’ Labels [EN]-[FR]-[NL]
August 14, 2007
Solvay launches Peracetic Acid production in China
State-of-the-Art Proxitane® Plant now fully operational in Suzhou [EN]-[FR]-[NL]
August 10, 2007
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals announce receipt of an FDA action letter for bifeprunox, an investigational treatment for schizophrenia
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced today the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an atypical antipsychotic that was reviewed for the acute treatment of schizophrenia, as well as the maintenance of stable adult patients. [EN]-[FR]-[NL]
July 30, 2007
Dow and Solvay Form Joint Venture to Build Hydrogen Peroxide Plant in Thailand; Dow and BASF Continue to Pursue Plans for Thailand HPPO Plant [EN]-[FR]-[NL]
July 27, 2007
First half 2007 results
Solvay’s operating results of EUR 616 million for the 1st half of 2007, exceeding the excellent results for the 1st half of 2006 [EN]-[FR]-[NL]
July 24, 2007
SOLVIN moves to reap sustainable benefits from dynamic vinyls market
Focus on highly competitive production units [EN]-[FR]-[NL]
June 28, 2007
SOLVAY, SIBUR sign join venture agreement to build Russia’s first world-scale vinyls production plant
State-of-the art technology for a fast-growing market [EN]-[FR]-[NL]
June 22, 2007
Solvay Sodi expands soda ash production capacity in Devnya (Bulgaria) to provide for the growth of its clients
10th Anniversary of Privatization Highlights Success Story [EN]-[FR]-[NL]
June 14, 2007
Solvay and Thin Film Electronics sign agreement to develop and optimize materials for printed memories
Printed electronics pave way for major technological breakthrough with multiple new applications [EN]-[FR]-[NL]
May 22, 2007
With the Queen Elisabeth Medical Foundation, Solvay supports the fight against Charcot-Marie-Tooth disease
The quest to treat more effectively a neuro-degenerative disorder that affects one person in 2,500 [EN]-[FR]-[NL]
May 08, 2007
First quarter 2007 results
Further growth in operating results for the Solvay Group : +11% in the first quarter of 2007 [EN]-[FR]-[NL]
May 08, 2007
Annual Shareholders Meeting 2007
Speeches by the Chairmen - Toespraken van de Voorzitters - Discours des Présidents [EN]-[FR]-[NL]
May 07, 2007
Inergy Automotive Systems deploys its fuel systems business in China, India and Russia
The Solvay / Plastic Omnium joint venture supplies its automotive customers on strong-growth markets [EN]-[FR]-[NL]
May 02, 2007
Solvay Solexis expands Polyvinyledene fluoride (PVDF) production capacity in Tavaux (France)
Marketing and R&D efforts boost demand for SOLEF® [EN]-[FR]-[NL]
April 25, 2007
Solvay Pharmaceuticals files TEDISAMIL, a new cardiometabolic product for the treatment of atrial fibrillation and atrial flutter
Solvay announced today that its dossier for intravenous tedisamil (intended brand name: PULZIUM® IV), a new chemical entity coming from Solvay Pharmaceuticals R&D laboratories, has been filed for approval by the US Food and Drug Administration (FDA) as well as by the authorities of European Union countries. This means that the formal processing and review have begun. [EN]-[FR]-[NL]
April 05, 2007
Solvay’s green chemistry technology for the manufacturing of Epichlorohydrin is operational in Tavaux (France)
Group consolidates technological leadership of Epicerol™ process [EN]-[FR]-[NL]
April 02, 2007
Solvay affiliate Pipelife acquires Quality Plastics, a specialty pipes & fittings manufacturer
Pipelife reinforces product portfolio in fast-growing market, broadens geographical [EN]-[FR]-[NL]
March 30, 2007
SolVin considers new PVDC latex production unit
Serving Growing demand for barrier material [EN]-[FR]-[NL]
February 22, 2007
Solvay Solexis expands perfluoropolyethers (PFPE) production capacity in Spinetta Marengo (Italy)
Strong demand & growth prospects for innovative products Solvera®, Fluorolink® & H-Galden® [EN]-[FR]-[NL]
February 19, 2007
Solvay statement on press article published in « Vers l’Avenir” on February 19, 2007 [EN]-[FR]
February 15, 2007
2006 Results
2006 : another record year for Solvay,due to strong growth in operating performance. Growth in sales of 10% and in operating results of 21% [EN]-[FR]-[NL]
January 11, 2007
Solvay and Wyeth collaborate for discovery of anti-psychotics with novel mechanisms
Expansion of existing neuroscience agreement [EN]-[FR]-[NL]
December 23, 2006
Solvay statement on protection measures for workers exposed to Vinyl Chloride (VCM) [EN]-[FR]-[NL]
December 20, 2006
Solvay Innovation Trophy honors breakthrough technologies, social & environmental responsibility
Eight innovations developed within the Solvay group were distinguished During the Solvay Innovation Trophy (SIT) ceremony which took place today at Solvay headquarters in Brussels. [EN]-[FR]-[NL]
December 15, 2006
Solvay & SolVin partners in the “SANTO” expedition to the Vanuatu Islands: the most ambitious international scientific mission in the field of biodiversity
In partnership with the Royal Belgian Institute of Natural Sciences, the Solvay Group and SolVin are pleased to announce their participation in the most ambitious international scientific mission ever undertaken in the field of biodiversity: the SANTO 2006, Biodiversity in danger expedition to the island of Santo, one of the Vanuatu Islands lying right in the middle of the South Pacific. [EN]-[FR]-[NL]
December 11, 2006
Solvay Pharmaceuticals withdraws its marketing authorization application for SYNORDIA® in Europe
Solvay Pharmaceuticals announced today that its subsidiary, Fournier Laboratories Ireland Ltd, formally notified the European Medicines Agency (EMEA) of its decision to withdraw its application for a centralized marketing authorization for SYNORDIA® in Europe. [EN]-[FR]-[NL]
December 08, 2006
Solvay’s SLV 319 obesity candidate treatment advances in phase II clinical trials
Triggering a milestone payment from co-development and co-commercialization partner Bristol-Myers Squibb. [EN]-[FR]-[NL]
December 08, 2006
Mercury Electrolysis
Statement by Solvay regarding the report published in the Belgian press on 8 December 2006 [EN]-[FR]-[NL]
November 28, 2006
Solvay launches, environmentally-friendly biocide for eradication of life-threatening hospital ‘superbugs’
Perestane® effective against Clostridium difficile and MRSA [EN]-[FR]-[NL]
November 27, 2006
Solvin launches NANOVIN®, a vinyl nanocomposite ‘smart material’
Innovation opens new commercial opportunities [EN]-[FR]-[NL]
October 27, 2006
Nine months 2006 results
Excellent operating results from the Solvay Group for the first nine months of 2006, reflecting further sustained growth in the third quarter [EN]-[FR]-[NL]
October 27, 2006
Solvay interim dividend increases to EUR 0.80
New Calculation Method will Reflect Progress of Dividend [EN]-[FR]-[NL]
October 24, 2006
Solvay, Quintiles announce five-year renewal of drug development strategic alliance
Renewal reflects success of alliance, first formed in 2001, in accelerating Solvay pipeline [EN]-[FR]-[NL]
October 16, 2006
Solvay expands, upgrades ultra polymer production in Panoli (India)
Launch of KetaSpire™, a new polyether ether ketone (PEEK) product line [EN]-[FR]-[NL]
October 12, 2006
Solvay Pharmaceuticals and Wyeth announce submission of new drug application for Bifeprunox to treat schizophrenia
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announce today that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) for bifeprunox, an investigational, new generation atypical antipsychotic for treatment and maintenance of stability of schizophrenic patients. [EN]-[FR]-[NL]
October 11, 2006
Seven key electro-intensive companies active in Belgium propose innovative power sourcing mechanism
A group of 7 key electro-intensive industrial companies active in Belgium, called “Blue Sky Project” (Air Liquide Industries Belgium, Arcelor Mittal, BASF Antwerpen, Duferco, Solvay, Tessenderlo Chemie and Umicore), announces that it has designed and proposed an innovative power sourcing mechanism. [EN]-[FR]-[NL]
October 03, 2006
Solvay Investor Day
Presentations [EN]
September 27, 2006
BASF, Dow, Solvay partnership breaks new ground with innovative HPPO technology in Antwerp
Environmentally friendly plant reduces waste water and energy usage [EN]-[FR]
September 13, 2006
Solvay pioneers e-billing solution in Europe
An innovative customer oriented offering compliant with strict EU rules [EN]-[FR]-[NL]
August 31, 2006
Solvay joins advanced materials venture capital fund
Exploring new business developments in information and communications technologies [EN]-[FR]-[NL]
August 30, 2006
Solvay Indupa launches ambitious plan to expand and upgrade vinyls production in Brazil
Capacity increase in Santo Andre to meet fast-growing Latin American demand [EN]-[FR]-[NL]
August 21, 2006
Solvay to launch fluorochemicals production in China
Joint Venture Paves the Way for Development of High-Value Fluorine Business in Asia [EN]-[FR]-[NL]
July 28, 2006
First half 2006 results
Excellent operating results for the Solvay group in the 1st half of 2006, again reflecting strong growth
[EN]-[FR]-[NL]
July 25, 2006
Umicore and Solvay launch Solvicore to develop and supply core technology for fuel cell industry
Joint Venture for Membrane Electrode Assemblies (MEA) Started Operations [EN]-[FR]-[NL]
July 19, 2006
Solvay submits Synordia®
( fenofibrate/ metformin) for EU approval
Building out the fenofibrate franchise with a new fixed-dose combination product [EN]-[FR]-[NL]
July 14, 2006
Egeplast acquires innovative Solvay technology
for high resistance, fully recyclable tubing
Solvay announces today that it has concluded an agreement for the transfer of its HexelOneTM reinforced plastic pipe technology to Egeplast Werner Strumann GmbH & Co. KG, the German polyethylene pipes manufacturer. [EN]-[FR]-[NL]
July 12, 2006
Solvay Pharmaceuticals Settles Lawsuit against Pseudo-Generic to CREON® MINIMICROSPHERES®
Solvay announces today that its United States subsidiary Solvay Pharmaceuticals, Inc. has settled a lawsuit filed against Global Pharmaceuticals and Impax Laboratories, Inc. alleging that the companies falsely advertised and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals’ CREON® MINIMICROSPHERES® (Pancrelipase Delayed-release Capsules, USP).
[EN]-[FR]-[NL]
July 05, 2006
Solvay welcomes Abbott & Astrazeneca deal to develop for the United States a new single pill combination therapy for comprehensive lipid management
Endorsing the Future Value of the Fenofibrate Franchise [EN]-[FR]-[NL]
June 30, 2006
Solvay to launch specialty polymer production in China
PTFE Micronized Powder Facility to Serve Buoyant Asian Markets [EN]-[FR]-[NL]
May 24, 2006
Success of Solvay EUR 500,000,000 hybrid security issue
SOLVAY S.A, through its French, fully-owned subsidiary SOLVAY FINANCE S.A, today successfully priced EUR 500 million Bonds achieving a coupon of 6.375% over 10 years. [EN]
May 16, 2006
Solvay is founding member of Exeltium, the French grouping of electro-intensive industries: an innovative solution for sustainable control of energy costs
The Solvay group is pleased to participate in the foundation of Exeltium, the grouping of electro-intensive industries active in France, whose creation was announced yesterday by the French Ministry of the Economy, Finances and Industry. [EN]-[FR]-[NL]
May 15, 2006
Solvay completes acquisition of GHARDA, after Mississippi Polymer Technologies: expansion into ultra high performance polymers in India & U.S.
PEEK and Parmax® to Enhance Solvay Advanced Polymer’ Ultra Polymers Product Line [EN]-[FR]-[NL]
May 12, 2006
Solvay makes MEUR 75 million capital gain on sale of stake in S.A. Financière Keyenveld
Solvay announces that its subsidiary Mutuelle Solvay has sold today a shareholding of 49.6% in S.A. Financière Keyenveld to Union Financière Boël. [EN]-[FR]-[NL]
May 11, 2006
SolVin invests EUR 50 million to concentrate vinyl production on global size plants, optimizes logistics & product range
Competitiveness enhanced with larger capacities, innovative products [EN]-[FR]-[NL]
May 09, 2006
First Quarter 2006 Results
Excellent results for the Solvay Group in the 1st quarter of 2006 [EN]-[FR]-[NL]
May 09, 2006
Annual Shareholders Meeting 2006
Minutes & Speeches by the Chairmen - Notulen & Toespraken van de Voorzitters - Procès-verbaux & Discours des Présidents [EN]-[FR]-[NL]
May 08, 2006
Solvay Denies 2006 Profit Forecast Published in Belgian Newspaper De Tijd [EN]
May 04, 2006
Solvay Pharmaceuticals awarded $298 million, five-year contract by U.S. department of Health & Human Services for flu pandemic preparedness
Contract Covers Development of Cell-Based Influenza Vaccines and Planning for a U.S. Manufacturing Facility [EN]-[FR]-[NL]
May 03, 2006
Solvay considers appealing EC decision on Peroxygen competition case
Solvay was informed today about a European Commission decision to impose a fine in the aggregate of EUR 193 million on the Solvay Group in relation with a cartel in the peroxygen sector in the European Union, dating back to the end of the nineties. [EN]-[FR]-[NL]
April 03, 2006
Solvay closes sale of Industrial Foils Business to Renolit
SOLVAY SA announces today that it has closed on March 31st the sale of its Industrial Foils business to RENOLIT AG, following the relevant social procedures and approval of the European competition authorities. [EN]-[FR]-[NL]
March 15, 2006
Solvay Pharmaceuticals signs additional agreement to get maximum global expansion for Androgel®
Leading male hormone treatment now comes to market on five continents [EN]-[FR]-[NL]
March 14, 2006
Solvay statement on settlement with US competition authority
Solvay announced today that it had reached agreement with the United States Department of Justice, in which it admitted to anticompetitive practices concerning the price of two peroxygen products [EN]-[FR]-[NL]
March 08, 2006
Umicore, Solvay join forces to develop and supply Core Technology for Fuel Cell industry
Two major European Groups in Joint Venture for Membrane Electrode Assemblies (MEA) [EN]-[FR]-[NL]
February 23, 2006
European Commission approves sale of Solvay’s Industrial Foils business to Renolit
SOLVAY SA takes note of the European Union’s competition authority decision of today, approving the sale of SOLVAY’s Industrial Foils business to RENOLIT AG. [EN]-[FR]-[NL]
February 16, 2006
2005 Results
New records for Solvay in 2005, after excellent results in 2004 [EN]-[FR]-[NL]
January 31, 2006
Solvay builds new Epichlorohydrin plant to meet growing demand with innovative production process
A strategic outlet for booming ‘green’ biodiesel industry [EN]-[FR]-[NL]
January 10, 2006
Solvay to boost ultra performance polymer portfolio with acquisition of Mississippi Polymer Technologies
Solvay expands its specialty polymer range with PARMAX® [EN]-[FR]-[NL]
December 15, 2005
Solvay Group - Interim Dividend
Solvay S.A’s. Board of Directors decided at their meeting on December 14, 2005 to distribute on January 12, 2006 a net interim dividend of EUR 0.70 per share for the 2005 financial year, i.e. unchanged compared to the interim dividend for the 2004 financial year. [EN]-[FR]-[NL]
December 15, 2005
Solvay signs agreement to acquire innovative specialty polymers business from Gharda (India)
New R&D, manufacturing unit in India for
global development and production of innovative materials
[EN]-[FR]-[NL]
December 08, 2005
Solvay creates incubator for innovative Start-ups in its research and technology centre in Brussels
Start-up company Artelis first to benefit from high tech environment [EN]-[FR]-[NL]
December 02, 2005
Ernest Solvay meets Albert Einstein: an industrialist dedicated to innovation
An exhibition in Brussels celebrates the life of a genius [EN]-[FR]-[NL]
November 29, 2005
CILANSETRON; Solvay Pharmaceuticals suspends registration activites in the U.S., while discussions in Europe continue
Solvay Pharmaceuticals announced today it has suspended regulatory activities for cilansetron with the United States regulatory agency, the Food and Drug Administration. [EN]-[FR]-[NL]
November 29, 2005
Bifeprunox: update on registration submission plan following clinical phase III results
Solvay Pharmaceuticals announces today that Solvay and its European partner H Lundbeck A/S will initiate additional phase III comparative clinical work in order to satisfy European Union requirements. [EN]-[FR]-[NL]
November 28, 2005
Solvay Pharmaceuticals completes market authorization in 28 European countries for Duodopa® - its treatment for advanced Parkinson’s disease.
Solvay Pharmaceuticals has obtained market authorization for DUODOPA®, the product for treating advanced Parkinson’s disease in 28 European countries. [EN]-[FR]-[NL]
November 18, 2005
Solvay and Chemical Products Corporation launch Global Barium Strontium joint venture
Creation of SOLVAY & CPC Barium Strontium GmbH & Co. KG enhances competitiveness [EN]-[FR]-[NL]
November 14, 2005
Solvay welcomes outcome of Fenofibrate intervention and event lowering in diabetes (field) study
Important news for Solvay Pharmaceuticals’ fenofibrate franchise [EN]-[FR]-[NL]
October 28, 2005
Nine months 2005 results
Sales (+15%) and operating results (+24%) for the first 9 months of 2005 greatly improved for the Group in its three sectors
Group net income (EUR 685 million) up 65% with cash flow exceeding EUR 1 billion [EN]-[FR]-[NL]
October 12, 2005
Solvay’s Fluvoxamine maleate is first drug approved for the treatment of social anxiety disorder in Japan
SOLVAY PHARMACEUTICALS announces today that Meiji Seika Kaisha Ltd. (Tokyo) and Solvay Seiyaku K. K. (Tokyo) obtained approval of additional indication of Social Anxiety Disorder... [EN]-[FR]-[NL]
September 26, 2005
Solvay and Pronova Biocare sign license agreement for Omacor® to expand Solvay’s cardiology portfolio in Asia
New markets for omega-3 treatment [EN]-[FR]-[NL]
September 14, 2005
Solvay creates high performance materials R&D and marketing platform in china
New location in Shanghai paves the way for further expansion [EN]-[FR]-[NL]
September 06, 2005
Solvay Pharmaceuticals launches DUODOPA® - its treatment for advanced Parkinson’s disease - in 12 new European countries
New markets for Solvay’s continuous dopaminergic stimulation (CDS) treatment [EN]-[FR]-[NL]
August 24, 2005
Solvay successful in friendly bid to acquire Specialty Chemicals company Girindus AG
SOLVAY ORGANICS GmbH announces that it successfully completed its public bid on GIRINDUS AG - a listed specialty chemicals company based in Bensberg, Germany. [EN]-[FR]-[NL]
August 02, 2005
Solvay and Berna Biotech sign a license agreement for Aerugen®, a vaccine against
Pseudomonas aeruginosa in Cystic Fibrosis patients
Solvay Pharmaceuticals and Berna Biotech Ltd announce today that they have signed a commercialization and license agreement for Aerugen®, a vaccine for the prevention of Pseudomonas aeruginosa (PA) infection in Cystic Fibrosis (CF) patients. [EN]-[FR]-[NL]
July 29, 2005
First half 2005 results
Presentation [EN]
July 29, 2005
First half 2005 results
Sales (+16%) and operating profits (+33%) up strongly in the 1st half of 2005 - Group net profit (EUR 509 million) more than doubled in the 1st half [EN]-[FR]-[NL]
July 28, 2005
Solvay completes acquisition of Fournier Pharma
Solvay announced that it has completed the acquisition of 100% of Fournier Pharma, following the successful completion of social and regulatory procedures worldwide. [EN]-[FR]-[NL]
July 27, 2005
Solvay finalizes agreement to sell Industrial Foils business to Renolit
SOLVAY SA announces today that it has signed a final agreement aiming at the sale of its entire Industrial Foils business, active in the production, marketing and sales of plastic foils and sheets to RENOLIT AG. [EN]-[FR]-[NL]
July 12, 2005
Solvay finalizes agreement to buy Fournier Pharma
Solvay announced today that it has signed a final purchase agreement with the shareholders of Fournier Pharma for the acquisition of 100% of the company. [EN]-[FR]-[NL]
June 30, 2005
MHRA requests further information on Cilansetron, Solvay ‘s proposed treatment for irritable bowel syndrome with diarrhea predominance (D-IBS) [EN]-[FR]-[NL]
June 23, 2005
Solvay launches friendly bid to acquire specialty chemicals company Girindus AG
Group creates new business unit in the Chemicals sector [EN]-[FR]-[NL]
June 22, 2005
Solvay to launch production of fluorine specialties in Asia
A new facility in Korea to serve the world’s fastest growing markets [EN]-[FR]-[NL]
June 13, 2005
Solvay is Solar Impulse’s technological partner
Innovation from a leading industrial group serving sustainable development and state-of-the-art technologies
[EN]-[FR]-[NL]
June 02, 2005
Annual Shareholders Meeting 2005
Speeches by the Chairmen - Toespraken van de Voorzitters - Discours des Présidents [EN]-[FR]-[NL]
May 12, 2005
Solvay Solexis expands fluoromaterials production to speed up growth
A major investment in Spinetta Marengo (Italy) to confirm world leadership [EN]-[FR]-[NL]
May 10, 2005
Solvay signs agreement aiming at selling Industrial Foils business to Renolit A.G.
A new platform for the development of a world-class company [EN]-[FR]-[NL]
May 03, 2005
Important appointments for 2006 at the top of the Solvay Group
In full agreement with those concerned and in accordance with the rules of corporate governance which the company has adopted, the Board of Directors of Solvay announces the following important appointments for 2006 at the top of the Solvay Group [EN]-[FR]-[NL]
April 29, 2005
First Quarter 2005 Results
Sales (+14%) and operating earnings (+20%) up strongly in the first quarter of 2005 [EN]-[FR]-[NL]
April 28, 2005
Solvay Solexis implements award-winning polymerization technology to serve industry with "pseudoliving" materials for extreme applications
Successful launch of high-value Tecnoflon® PFR 45HT perfluoroelastomer with unique properties [EN]-[FR]-[NL]
April 05, 2005
Solvay to launch sodium bicarbonate production in Bernburg (Germany)
New Plant to Serve North-Eastern Europe with Competitive, Environmentally-Friendly Specialty [EN]-[FR]-[NL]
March 24, 2005
Solvay signs agreement aiming at acquisition of Fournier Pharma
A major strategic move to accelerate sustainable, profitable growth [EN]-[FR]-[NL]
March 24, 2005
Solvay signs agreement aiming at acquisition of Fournier Pharma - Analyst presentation
A major strategic move to accelerate sustainable, profitable growth [EN]-[FR]-[NL]
March 16, 2005
Cetrorelix progresses to full development in Solvay Pharmaceuticals for the treatment of Endometriosis in women
SOLVAY PHARMACEUTICALS has decided to undertake full Phase III development with cetrorelix for the treatment of endometriosis in women. [EN]-[FR]-[NL]
February 28, 2005
Vinythai: Solvay’s vinyls affiliate in Thailand expands upstream capacity secures feedstock supply
Following Vinythai’s decision to double its Vinyl Chloride Monomer (VCM) production, Solvay has announced today that the Board of its Thai vinyls affiliate has now decided to fully integrate upstream by also doubling the Chlorine and Ethylene Di-Chloride (EDC) production capacity at its plant in Map Ta Phut. [EN]-[FR]-[NL]
February 23, 2005
Final 2004 results
2004 results up 26% to record level of EUR 541 million, 5.6% increase of dividend in 2004 to EUR 1.90 per share [EN]
February 17, 2005
Solvay Pharmaceuticals will supply Norway with special vaccines in the event of an influenza pandemic
Solvay Pharmaceuticals today announce that it has signed an agreement with the Norwegian authorities whereby Solvay Pharmaceuticals will supply influenza vaccines to Norway in the case of a pandemic. [EN]-[FR]-[NL]
February 03, 2005
Parkinson's: Solvay Pharmaceuticals moves SLV 308 compound into phase III clinical development
SOLVAY PHARMACEUTICALS announces today it has advanced its R&D project known under code name SLV308 into a full phase III development program [EN]-[FR]-[NL]
January 21, 2005
Solvay Pharmaceuticals completes acquisition of Neopharma in Sweden
SOLVAY PHARMACEUTICALS announces the successful completion of the acquisition of NEOPHARMA AB, a company based in Uppsala, Sweden, as shareholders representing 100% of the company’s capital accepted the friendly takeover bid launched by Solvay last December. [EN]-[FR]-[NL]
January 21, 2005
Solidarity with Asia: EUR 250 000 to help children in need
The Solvay group has decided to participate in the task of rebuilding decent living conditions along the Indian Ocean coastlines. [EN]
January 20, 2005
Inergy Automotive Systems seeks to acquire Yapp, the chinese fuel systems market leader
Inergy Automotive Systems and State Development Investment Corporation (SDIC) of the People’s Republic of China announce today that they have signed a Memorandum of Undertsanding whereby Inergy would acquire a majority stake in Yangzhou Yapp Automotive Plastic Parts Company Limited. [EN]-[FR]-[NL]
January 17, 2005
Solvay signs agreement aiming at selling rigid plastic foils activities to Ineos
Solvay SA announces today that it has signed a memorandum of understanding with Ineos aiming at the sale of its subsidiaries active in the production, marketing and sales of rigid plastic foils, Adriaplast and Caleppiovinil, to Ineos. [EN]-[FR]-[NL]
January 07, 2005
Solvay finalizes sale of interest in BP Solvay Polyethylene joint ventures to BP
Solvay SA announces today that it has finalized the sale of its interest in the BP Solvay Polyethylene joint ventures to BP [EN]-[FR]-[NL]
December 22, 2004
Hydrogen Peroxide: Solvay expands USA capacity and plans new investments in Chile
High productivity technology implemented in the Americas [EN]-[FR]-[NL]
December 21, 2004
Solvay announces major expansion in sulfone specialty polymers
New facility will nearly triple polyethersulfone (PES) capacity. [EN]-[FR]-[NL]
December 20, 2004
Solvay Pharmaceuticals launches bid to acquire Neopharma in Sweden
SOLVAY PHARMACEUTICALS announces today the launch of a friendly bid to acquire NEOPHARMA, a company based in Uppsala, Sweden. [EN]-[FR]-[NL]
December 16, 2004
Interim Dividend 2004
net interim dividend of EUR 0.70 per share for the 2004 financial year [EN]-[FR]-[NL]
December 10, 2004
Solvay Pharmaceuticals acquires Italmex in Mexico
Solvay strengthens position in Latin America [EN]-[FR]-[NL]
November 24, 2004
Solvay and Chemical Products Corporation seek to create global barium strontium joint venture
Alliance to enhance competitiveness on challenging market [EN]-[FR]-[NL]
November 17, 2004
Solvay and Petrovax combine ground breaking skills to produce new flu vaccines in Russia
Solvay Pharmaceuticals cell line to feed Petrovax production unit in Moscow. [EN]-[FR]-[NL]
November 10, 2004
Vinythai to double VCM capacity
New partnership to take advantage of growing vinyls market in Asia [EN]-[FR]-[NL]
November 09, 2004
Solvay reduces its stake in Sofina from 13% to 6.5%
The Solvay group exchanged yesterday part of the stake it holds in Sofina [EN]-[FR]-[NL]
November 08, 2004
Solvay Pharmaceuticals and Novozymes to develop Biotech treatment of pancreatic exocrine insufficiency
A new generation of products to expand pancreatic enzymes franchise [EN]-[FR]-[NL]
November 04, 2004
Solvay launches its vinyls technology in China with ground-breaking license agreement
Solvay SA announces today that it has signed a license agreement to supply its vinyl chloride monomer technology to Singpu Chemical Industries Co., Ltd. for the construction of a new production unit in Taixing (Jiangsu Province, People’s Republic of China). [EN]-[FR]-[NL]
November 03, 2004
Solvay sells its stake in BP Solvay Polyethelene joint ventures to BP
Exercise of put option confirms Solvay’s focus on specialty polymers [EN]
October 29, 2004
Nine months 2004 results
Increase of 40% [EN]
October 19, 2004
Solvay Joins Fuel Cell Venture Capital Fund
Market-driven intelligence will boost Solvay research in sustainable and clean power source [EN]-[FR]-[NL]
October 19, 2004
Solvay Plastics… Innovative Composition” at K2004 International Plastics Trade Fair
Solvay will hinge its exhibition at the K2004 International Plastics Trade Fair in Düsseldorf, Germany, [EN]
October 18, 2004
Solvay Secures Cost-efficient Power Supply for Rosignano (It.) Site
Electrabel builds State-of-the-art, environmentally friendly Power Station [EN]-[FR]-[NL]
October 14, 2004
Novel agreement with Quintiles/Pharmabio Development accelerates throughput of Solvay Pharmaceuticals R&D Pipeline
Clinical development specialist endorses SOLVAY’S R&D Portfolio. SOLVAY PHARMACEUTICALS and QUINTILES today announce, with immediate effect, a novel agreement
[EN]-[FR]-[NL]
October 01, 2004
Inergy Automotive Systems innovation provides California with ultra clean cars
The Super Ultra Low Emission Vehicle (SULEV) fuel system developed by Inergy Automotive Systems, a joint subsidiary of Solvay SA and Plastic Omnium [EN]-[FR]-[NL]
September 02, 2004
Solvay Confirms Intention to Create Hydrogen Peroxide Joint Venture with BASF
Innovative Megaplant based on Solvay Technology to be built in Antwerp(B) [EN]-[FR]-[NL]
July 30, 2004
First half 2004 results
Increase of 19% [EN]-[FR]-[NL]
July 30, 2004
First half 2004 results
Presentation [EN]-[FR]-[NL]
July 19, 2004
Solvay Pharmaceuticals obtains European and Canadian approval for TEVETEN® PLUS
Solvay Pharmaceuticals announced today that it has obtained European marketing approval for its new cardiovascular combination drug TEVETEN® PLUS. [EN]-[FR]-[NL]
July 01, 2004
Solvay Pharmaceuticals Inc. submits New Drug Application
to the United States Food and Drug Administration for cilansetron
to treat Irritable Bowel Syndrome with diarrhea predominance in men and women
Solvay Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) for cilansetron [EN]-[FR]-[NL]
June 22, 2004
Solvay Pharmaceuticals gets european marketing approval for new virosomal influenza vaccine: Invivac®
Solvay Pharmaceuticals announced today that it has obtained European marketing approval for its new virosomal influenza vaccine: INVIVAC®. [EN]-[FR]-[NL]
June 14, 2004
Solvay concludes sale of minority stake in non-core salt business to K+S
Solvay has finalized the sale of its 38% stake in ESCO (European Salt Company GmbH & Co. KG) to K+S Aktiengesellschaft, which was initially announced in February 2004. [EN]-[FR]-[NL]
June 03, 2004
Solvay and Wyeth see peak year sales in excess of USD 1 billion for new antipsychotic compound bifeprunox
Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the
treatment of schizophrenia . [EN]-[FR]-[NL]
May 19, 2004
Cilansetron: significant symptom relief reported in phase III clinical trial patients with irritable bowel syndrome with diarrhea predominance
Solvay Pharmaceuticals unveiled this week results from a six-month study of both male and female patients and from a subgroup analysis of males with Irritable Bowel Syndrome with Diarrhea predominance (IBS-D). [EN]-[FR]-[NL]
May 17, 2004
Bristol-Myers Squibb and Solvay Pharmaceuticals in development and commercialization agreement involving novel obesity compound
Bristol-Myers Squibb Company (NYSE: BMY) and Solvay Pharmaceuticals today announced that the companies have entered into a worldwide agreement for the Solvay compound SLV319... [EN]-[FR]-[NL]
May 13, 2004
Solvay Soda Ash takes first step toward major chemical alliance in China
NCI, Subsidiary of Sinopec, identified as the appropriate potential partner [EN]-[FR]-[NL]
May 10, 2004
Solvay Pharmaceuticals signs agreement for major geographical expansion in male hormone treatment with Androgel®
Solvay Pharmaceuticals today announces the signing of agreements for important geographical expansions to its best selling product ANDROGEL® with the French pharmaceutical company Besins International.
[EN]-[FR]-[NL]
May 04, 2004
Werner Cautreels to succeed Jurgen Ernst at the head of Solvay Pharmaceuticals
From January 1, 2005, Werner Cautreels, currently Global Vice President RD of Solvay’s Pharmaceutical Sector, will succeed Jürgen Ernst... [EN]-[FR]-[NL]
April 29, 2004
Increase of first quarter results 2004
Stable sales and net income of the Group up by 20% [EN]-[FR]-[NL]
April 01, 2004
Solvay Pharmaceuticals and Wyeth Pharmaceuticals sign agreement for extensive co-operation in psychiatric compounds
Solvay Pharmaceuticals today announced that it has signed extensive agreements with Wyeth Pharmaceuticals, a division of Wyeth. [EN]-[FR]-[NL]
March 30, 2004
Solvay increases the operational autonomy of its pharmaceuticals sector and unites its plastics and processing sectors
The Solvay group today announces a new step in the implementation of its strategy: the Group intends to simplify and increase the efficiency of its organization, with two important structural changes. [EN]-[FR]-[NL]
March 26, 2004
Final 2003 results
Resilient 2003 results (EUR 430 million). Despite a very strong EUR and a weak economic environment, the Solvay group ends 2003
with a net income decrease of only 13% compared to record 2002 results. 2003 dividend maintained (EUR 1.80 per share). [EN]-[FR]-[NL]
February 13, 2004
Solvay Group preliminary 2003 results
Resilient 2003 results (EUR 430 million).
Despite a very strong EUR and a weak economic environment, the Solvay group ends 2003 with a net income decrease of only 13% compared to record 2002 results. [EN]-[FR]-[NL]
February 06, 2004
Solvay intends to sell minority stake in non-core salt business to K+S
Solvay S.A. and K+S Aktiengesellschaft announce today that they have signed a non-binding letter of intent aiming at the sale of Solvay’s 38% stake in esco (European Salt Company GmbH & Co. KG) to K+S, which already holds the other 62% of the joint venture. [EN]-[FR]-[NL]
February 04, 2004
Solvay innovation doubles productivity of hydrogen peroxide plant
Solvay has successfully demonstrated the sustainability at industrial scale of the innovative high-yield process it has developed for the manufacturing of Hydrogen Peroxide (H2O2) at its Solvay Interox industrial pilot plant in Povoa, Portugal. [EN]-[FR]-[NL]
January 15, 2004
Solvay, Kobelco eco-solutions create joint venture to introduce Vinyloop® in Japan
First Asian Unit of Solvay’s Innovative PVC Recycling Process Scheduled for 2005
[EN]-[FR]-[NL]
December 18, 2003
Interim Dividend
Net interim dividend of EUR 0.70 per share for the 2003 financial year [EN]-[FR]-[NL]
October 31, 2003
Weak economy and strength of the euro affected the results (-25%) - Volumes and market shares unaffected
Sales of the Solvay group for the first nine months of 2003 were EUR 5,685 million, down 5% compared to the same period of 2002. At constant exchange rates, they would have increased by 1%. [EN]-[FR]-[NL]
October 29, 2003
Solvay presses ahead with Cilansetron registrations following favorable phase III clinical findings
SOLVAY announces today that headline results from the first two large placebo-controlled phase III efficacy studies show convincing evidence for the patient benefits of cilansetron [EN]-[FR]-[NL]
September 22, 2003
IBISCA Mission for the SolVinBretzel in Panama
From 22 September to 31 October 2003, the “SolVinBretzel” Canopy Raft will be taking part in a new scientific adventure. This time it will host twenty international scientists on top of Panama’s tropical forest for an international research mission into insect biodiversity. [EN]-[FR]-[NL]
September 02, 2003
Solvay pharmaceuticals and Lundbeck move into clinical phase III with joint schizophrenia treatment, bifeprunox
Solvay Pharmaceuticals and H. Lundbeck A/S today announce their joint decision to move bifeprunox into clinical phase III with immediate effect. The decision to move into phase III follows the successful completion of the joint phase II program. In December 2000 the two companies announced that they would join forces in the development and marketing of this atypical antipsychotic, bifeprunox. [EN]-[FR]
July 31, 2003
Strengthening of the euro and weak economic activity affected results (-18%) / volumes and competitiveness remain generally strong
The strategy of strengthening Specialties is bearing fruit, in particular the growing share of Specialty Polymers for which the results and the margin are increasing.
[EN]-[FR]-[NL]
June 18, 2003
Solvay in New Partnership to Launch Industrial Operations
on Growing Russian PVC Compounds Market
Solvay announces today that it has signed an agreement with Nikos, a private Russian industrial group, to create Soligran, a polyvinyl chloride (PVC) compounds joint venture in Russia. [EN]-[FR]-[NL]
June 05, 2003
Annual Shareholders Meeting 2003
Speeches by Baron Daniel Janssen and Mr. Aloïs Michielsen [EN]-[FR]
May 28, 2003
Solvin to secure production in larger world-class plants
Solvin announced its decision to shut down its vinyl chloride monomer (VCM) and polyvinyl chloride (PVC) operations in Ludwigshafen, Germany, on January 1, 2006 - as these operations are not run in world-scale plants. [EN]
April 30, 2003
First quarter 2003 results
The Solvay Group completed the first quarter of 2003 with consolidated net income of EUR 98 million, up 13% from the earnings of the first quarter of 2002 (EUR 87 million). [EN]-[FR]-[NL]
April 15, 2003
Annual Report 2002
For 140 years, ingenuity has driven growth at Solvay. [EN]
April 14, 2003
Solvay statement on European Commission Inspection
Officials from the European Commission's Competition Directorate-General came to the headquarters of the Solvay group in Brussels on March 25, 2003. [EN]
March 28, 2003
SOLVAY GROUP : EXCELLENT YEAR 2002
Record net earnings confirmed, up 23% [EN]-[FR]-[NL]
March 24, 2003
Solvay reinforce fluorine specialties
New production plant for SOLKANE 365 mfc is operational [EN]-[FR]-[NL]
February 20, 2003
SOLVAY PHARMACEUTICALS SIGNS RESEARCH AGREEMENT
Solvay Pharmaceuticals and Hormos Medical Corporation (Finland) have signed a research collaboration and license agreement in the women s health therapeutic area [EN]-[FR]-[NL]
February 11, 2003
SOLVAY GROUP HAS EXCELLENT YEAR IN 2002
Preliminary 2002 earnings show increase of 23% [EN]-[FR]-[NL]
February 11, 2003
SOLVAY LAUNCHES ITS NEXT GENERATION INTERNET GATEWAY
Solvay announces today the launch of its next generation corporate web site. [EN]-[FR]-[NL]
January 30, 2003
Solvay Pharmaceuticals builds new factory for cell-cultured influenza vaccine Influvac®TC
Solvay Pharmaceuticals announced today that it will invest more than EUR 50 million in a new integrated facility for the production of influenza vaccines generated through an innovative cell culture method. [EN]-[FR]-[NL]
December 13, 2002
Solvay wraps up acquisition of Ausimont; complies with European Commission requests
Degussa acquires Ausimont's H2O2 and Persalts activities in Bussi (Italy) [EN]-[FR]-[NL]
December 03, 2002
Cetrorelix poised to swell Solvay's pharmaceutical portfolio
GnRH antagonist licensed from biopharma company Zentaris [EN]-[FR]-[NL]
November 28, 2002
Solvay Solexis: Birth of a global leader in fluorinated materials
The Solvay Group is merging its fluoropolymers activities with those of Ausimont into a new company, which will be officially launched under the name SOLVAY SOLEXIS on January 1, 2003. [EN]
November 12, 2002
Solvay Interox to meet increased sodium percarbonate demand with new capacity in North America
Solvay Interox, Inc. will add 50 kilotons of sodium percarbonate (PCS) capacity at its Deer Park, Texas manufacturing site. [EN]
August 27, 2002
Solvay in agreement with Dyneon to sell Solvay Fluoropolymers, Inc. in Decatur (USA)
Sale of PVDF activities taken to comply with conditions set by competition authorities for Ausimont acquisition [EN]-[FR]-[NL]
July 31, 2002
SOLVAY GROUP: RESULTS OF FIRST HALF OF 2002 UP 15 %
Strong growth in Pharmaceuticals and Plastics Sectors.
Ausimont s half-year results included for first time since its acquisition. [EN]-[FR]-[NL]
May 23, 2002
Agreement with BASF Points to New Growth Potential for Solvay's Hydrogen Peroxide Business
Solvay S.A. announced today that it has signed an agreement with BASF which paves the way towards new applications for Hydrogen Peroxide (H2O2) as an environmentally friendly intermediate product in the chemical industry. [EN]-[FR]-[NL]
May 23, 2002
Solvay Pharmaceuticals Inc. Suspends Sales of LUVOX® in the United States after FDA Exclusivity Expiration
Solvay Pharmaceuticals Inc., Marietta, Georgia, has voluntarily requested the withdrawal of the U.S. Food & Drug Administration's original approval for LUVOX® (fluvoxamine maleate) Tablets, in the United States only. [EN]-[FR]-[NL]
May 07, 2002
Solvay successfully completes acquisition of Ausimont, confirms leadership in fluorinated specialties
US and European competition authorities approved the Group's largest acquisition ever.
[EN]-[FR]-[NL]
March 18, 2002
SOLVAY transfers Teveten® Rights in the U.S. to Biovail Corporation
Solvay Pharmaceuticals Marketing & Licensing AG, an affiliate of Solvay S.A., announced today that it is transferring its rights for Teveten® (eprosartan mesylate) and Teveten® HCT (eprosartan mesylate and hydrochlorothiazide combination)in the United Stat [EN]-[FR]-[NL]
February 25, 2002
Breakthrough in recycling PVC composite waste:Start-up of first industrial unit using the VINYLOOP® process, in Ferrara (Italy)
The first industrial unit to use the Vinyloop® process started operating this month. It is at Solvay's Ferrara site, and will be able to regenerate PVC from at least 10,000 tonnes a year of waste plastic material. [EN]-[FR]-[NL]
February 12, 2002
Solvay concludes sale of automotive air systems and technical parts activities to Mann+Hummel
Solvay has finalized the sale of its automotive Air Induction Systems and Technical Parts activities to Mann+Hummel, which was initially announced last October. [EN]-[FR]-[NL]
January 14, 2002
Solvay welcomes EU green light for ESCO, the new salt joint venture with K+S
Solvay welcomes the decision of the EU competition authorities, approving the establishment of a salt joint venture between K+S Aktiengesellschaft (Kassel) and Solvay S.A. (Brussels). [EN]-[FR]-[NL]
December 21, 2001
AGREEMENT TO BUY AUSIMONT IS MAJOR THRUST
Solvay poised to achieve largest acquisition in the History of the Group [EN]-[FR]-[NL]
December 11, 2001
SOLVAY PHARMACEUTICALS EXPANDS CARDIOLOGY WITH OMACOR® FROM PRONOVA BIOCARE
SOLVAY PHARMACEUTICALS (BELGIUM) announced today the signing of a licensing agreement with PRONOVA BIOCARE (NORWAY) for the highly concentrated omega-3 polyunsaturated fatty acids (PUFA) product OMACOR®. [EN]-[NL]
December 05, 2001
SOLVAY signs distribution agreement with HENKEL for flat roof products in Germany and Austria
Solvay S.A., Brussels, and Henkel Bautechnik GmbH, Düsseldorf, concluded an alliance concerning flat roof products on the German and Austrian markets. [EN]-[FR]-[NL]-[DE]
November 28, 2001
Solvay enters into one-to-one talks with Montediso
Solvay entered into a process of one-to-one talks with the Montedison Group, aiming at the purchase of 100% of Ausimont and of 100% of its holding company, Agora. [EN]-[FR]-[NL]
November 20, 2001
SOLVAY to implement pioneering e-business and logistics solutions
ELEMICA signs logistics technology agreement with TRANSWIDE. [EN]-[FR]-[NL]
November 02, 2001
SOLVAY AND K+S SIGN AGREEMENT TO SET UP ESCO, THEIR SALT JOINT VENTURE
Solvay SA, Brussels and K+S Aktiengesellschaft, Kassel, have signed after detailed talks an agreement to set up a joint venture in the salt sector. [EN]-[FR]-[NL]
November 01, 2001
SOLVAY's AGREEMENT WITH BP ENTERS INTO FORCE
Strengthening of Solvay's position in high-margin Specialty Polymers - Birth of "BP SOLVAY POLYETHYLENE" joint ventures [EN]-[FR]-[NL]
October 30, 2001
Solvay unveils landmark technology to rejuvenate PVC building components
Extending lifetime of PVC products contributes to their sustainability. [EN]-[FR]-[NL]
October 23, 2001
SOLVAY AND TAKUMA IN AGREEMENT TO MARKET SODIUM BICARBONATE FOR FLUE GAS CLEANING IN JAPAN
First Asian launch of Solvay's novel technology for environmentally-friendly municipal solid waste incinerators (Neutrec®). [EN]-[FR]-[NL]
October 19, 2001
SOLVAY INTENDS TO SELL AUTOMOTIVE AIR SYSTEMS AND TECHNICAL PARTS ACTIVITIES TO MANN+HUMMEL
Memorandum of Understanding on the transfer of activities just signed. [EN]-[FR]-[NL]
September 19, 2001
SOLVAY and LPW finalize their agreement to buy business activities from each other.
Solvay will expand its industrial foils business by taking over Cova Products.
LPW will expand its decoration business by acquiring Alkor Deco, Vénilia, Veninov and Boekelo Decor. [EN]-[FR]-[NL]
September 14, 2001
Solvay's novel therapeutic agent SLV306 shows its early promise for the treatment of hypertension and congestive heart failure
SOLVAY PHARMACEUTICALS has demonstrated crucial proof-of-principle for its novel cardiology candidate therapeutic agent SLV306. [EN]-[FR]-[NL]
September 06, 2001
Solvay expands its successful peptide activities through the incorporation of Peptisyntha, Inc. in the US
Technological synergies and geographic expansion. [EN]-[FR]-[NL]
September 04, 2001
Further development in Fluorinated Specialties Industrialization of Solkane® 365mfc
Solvay Fluor - one of the main suppliers of fluorine chemicals - announces its decision to build a plant in Tavaux (France) for the large-scale production of Solkane® 365mfc, a new insulating and blowing agent having no effect on the ozone layer. [EN]-[FR]-[NL]
August 30, 2001
Solvay Signs Agreement with Kobe Steel Aiming At Introducing Vinyloop® in Japan
Solvay's innovative PVC recycling process takes first step in Asia. [EN]-[FR]-[NL]
August 06, 2001
FUNDAMENTAL STRATEGIC CHANGE FOR SOLVAY : SIGNATURE OF FINAL CONTRACTS WITH BP
Solvay has signed a binding agreement with BP, which represents a leap forward in its ongoing strategic repositioning towards fast growth and high added value in specialty products. [EN]-[FR]-[NL]
July 18, 2001
SOLVAY PHARMACEUTICALS moves ahead in Irritable Bowel Syndrome with cilansetron A clinical services agreement is signed WITH QUI
SOLVAY PHARMACEUTICALS has decided to move ahead with its phase III program with cilansetron, a 5HT3 antagonist for the treatment of irritable Bowel syndrome (IBS). [EN]-[FR]-[NL]
July 02, 2001
SOLVAY LICENSES IN NASAL DELIVERY TECHNOLOGY FOR INFLUENZA VACCINE FROM WEST PHARMACEUTICALS
Solvay announced today that it has signed a licensing agreement with West Pharmaceuticals (Lionville, Pennsylvania, US) for an intranasal influenza vaccine. [EN]-[FR]-[NL]
June 28, 2001
SOLVAY PHARMACEUTICALS GETS MARKETING APPROVAL FOR
Solvay Pharmaceuticals announced today that - as t [EN]-[NL]
June 20, 2001
Success prompts Solvay to lift inaugural EMTN issue to EUR 700,000,000
Solvay S.A. (A/A2 long term ratings by S&P and Moody's) launches today a EUR 700,000,000, 5 year eurobond issue. [EN]
June 18, 2001
Solvay and LPW intend to buy business activities from each other
Solvay would expand its industrial foils business by taking over Cova Products. - LPW would expand its decoration business by acquiring Alkor Deco, Venilia, Boekelo Folien and Veninov. [EN]-[FR]-[NL]
June 15, 2001
SOLVAY EXPANDS CAPACITY FOR CAPROLACTONE POLYMERS
SOLVAY Caprolactones has started a multi-stage expansion at its Warrington, UK site which will more than double its capacity for caprolactone polymers over the next three years. [EN]-[NL]
June 11, 2001
Solvay pioneers e-transactions on the Elemica Network
Solvay announces today that it is one of the front-runners in conducting contract business using enterprise resource planning (ERP) connections on Elemica, the neutral, global electronic network for the contract buying and selling of chemicals. [EN]-[FR]-[NL]
May 30, 2001
Solvay's Unimed and TAP join Forces to co-promote Androgel® in the USA
Unimed Pharmaceuticals, Inc., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., and TAP Pharmaceutical Products, Inc., the Japanese-American joint venture, today announced an agreement to co-promote AndroGel® 1%, a testosterone gel delivered on prescription only, in the United States. [EN]-[FR]-[NL]
May 29, 2001
Solvay increases its production capacity of sodium bicarbonate, in response to the strong growth of demand for BICAR®
Many uses of this specialty chemical with exceptional properties. [EN]-[FR]-[NL]
April 20, 2001
SOLVAY PHARMACEUTICALS proposes steps to create value faster in its Research and Development (R&D) centers
SOLVAY PHARMACEUTICALS has proposed concrete measures to improve effectiveness across its Research and Development (R&D) centers worldwide, as a result of the study which was launched last February. [EN]-[FR]
April 09, 2001
Solvay buys and expands manufacturing activity for influenza vaccine Influvac®
Solvay announced today that it has bought back the production unit for its influenza vaccine Influvac® from American Home Products Manufacturing BV in Weesp, the Netherlands. In 1997, when Fort Dodge (daughter of AHP) bought Solvay's animal health activities, including the production site, it was agreed that Fort Dodge would manufacture the bulk influenza vaccine on behalf of Solvay. [EN]-[FR]-[NL]
April 06, 2001
Solvay enters Russian PVC compounds market
A Western Pioneer in Russia. [EN]-[FR]-[NL]
April 04, 2001
Solvay backs young inventor and purchases stake in start-up company EcoPhos
Solvay and EcoPhos have just signed an agreement pertaining to an important research development in the chemicals sector, which entails Solvay's entry in the capital of EcoPhos. [EN]-[FR]-[NL]
March 30, 2001
SolVin Implements Industrial Plan, Increases Compe
SolVin today confirmed, persuant to the implementation of its industrial plan to improve competitiveness, the closure of BASF's VCM-PVC unit in Zandvliet (Belgium) in April 2001. [EN]-[FR]-[NL]
February 27, 2001
Solvay sets up new partnerships to continue fast implementation of e-business strategy
All Corporate websites poised to be revamped.
[EN]-[FR]-[NL]
February 22, 2001
SOLVAY PHARMACEUTICALS is studying effectiveness improvements across its Research and Development (R&D) centers. In total, Pharma R&D efforts are not reduced but refocused.
The objectives of the study are to seek the best ways -including the conclusion of more partnerships. [EN]-[FR]-[NL]
February 09, 2001
Solvay's Innovation Trophy 2000 rewards four projects;promotes culture, health, well-being and competitiveness
Aloïs Michielsen, chairman of Solvay's executive committee, awarded yesterday in Paris the Innovation Trophy 2000 to the project teams of four innovations that were successfully developed within the Solvay Group. [EN]-[FR]-[NL]
February 09, 2001
RECYCLING PLASTICS AND PVC
DOMINIQUE VOYNET FINDS OUT ABOUT INITIATIVES AND TECHNOLOGIES DEVELOPED BY SOLVAY. [EN]-[FR]-[NL]
December 27, 2000
Efficiency of safety systems demonstrated at Solvay Indupa (Bahia Blanca) after an alert of no consequence
Bahia Blanca, December 27, 2000. At 7:15 pm, local time, a small leak of chlorine gas occured in an electrolysis room of the chlorine production unit of Solvay Indupa in Bahia Blanca (Argentina). [EN]-[FR]
December 21, 2000
Lundbeck and Solvay pharmaceuticals co-operate on antipsychotic from phase II
Brussels, 21 December 2000 : H. Lundbeck A/S and Solvay Pharmaceuticals B.V. have today entered into a co-operation agreement on the development and marketing of an a-typical antipsychotic currently in clinical phase II development for the treatment of schizophrenia. [EN]-[FR]
December 19, 2000
Major activity exchange between Solvay and BP
SOLVAY announced that it signed with BP a Memorandum of Understanding aimed at strengthening its portfolio. [EN]-[FR]-[NL]
December 15, 2000
Inergy automotive systems signs letter of intent to build plant in slovakia
(Paris - December 14, 2000) - Ivan Miklos, Slovakia's Deputy Prime Minister for Economic Affairs, and Inergy Automotive Systems today signed a letter of intent concerning the construction of a plant in Lozorno, near Bratislava, the Slovak capital. [EN]-[FR]
December 14, 2000
Solvay Group - interim dividend readjusted in proportion to final dividend
Solvay S.A.'s Board of Directors decided at their meeting on December 14, 2000 to distribute on January 11, 2001 a net interim dividend of EUR 0.70 per share, compared to a net interim dividend of EUR 0.25 per share announced in December 1999. [EN]-[FR]-[NL]
December 07, 2000
Solvay and Bricsnet partner in online building marketplace
Solvay and Bricsnet today announced a partnership to bring its Solvay's building materials information online using the Bricsnet.com platform. [EN]-[FR]-[NL]
December 01, 2000
Peroxidos do Brasil starts to expand its hydrogen peroxide production to 90,000 tonnes per year.
PERÓXIDOS DO BRASIL LTDA., a joint venture between Solvay (Belgium) and Produtos Quimicos Makay (Brazil) started the expansion of its hydrogen peroxide production in Curitiba to 90,000 tons per annum. [EN]
October 20, 2000
Solvay and K+S intend to combine their salt businesses
Solvay SA, Brussels and K+S Aktiengesellschaft, Kassel, intend to join forces on the European salt market. [EN]-[FR]-[NL]
October 12, 2000
Solvay and Dacarto form a new company for PVC compounds in Brazil
Sao Paulo, October 12, 2000 --- The Solvay Group and the Brazilian company, Dacarto SA Industrias de Plasticos, formed yesterday a 50-50 joint venture, Dacarto Benvic SA, for PVC compound production. [EN]-[FR]-[NL]
October 03, 2000
Solvay establishes itself in the South American pharmaceutical market by acquiring the Brazilian company Sintofarma
Solvay (Brussels, Belgium) has acquired the pharmaceutical company Sintofarma in Sao Paulo, Brazil. [EN]-[FR]-[NL]
October 03, 2000
Reopening of the VCM & PVC units at Bahia Blanca (Argentina)
The vinyl chloride (VCM) and PVC production units of the Solvay Indupa plant in Bahia Blanca (Argentina) was reopened on 26 September, following the agreement given by the Argentine authorities. [EN]-[FR]-[NL]
September 22, 2000
SOLVAY Joins EURONEXT 100
SOLVAY SA will be listed among the top hundred European companies of the EURONEXT 100 index, whose composition was unveiled today in Paris. [EN]-[FR]
September 12, 2000
Solvay Polymers and Chevron Phillips Chemical Company Confirm the Construction of New U.S. High-Density Polyethylene Plant
HOUSTON, September 12, 2000 --- Solvay Polymers, Inc. and Chevron Phillips Chemical Company LP (CPC) have selected a CPC site in Texas, as the location for their jointly owned 700 million lb./yr. high-density polyethylene (HDPE) slurry loop plant. CPC and Solvay Polymers will each own 50 percent of the plant and will share its production of general-purpose blow molding HDPE resins. [EN]-[FR]-[NL]
September 05, 2000
PIPELIFE INTERNATIONAL SETS UP NEW COMPANY IN CHINA, STRENGTHENING ITS POSITION IN THE FAST GROWING SHANGHAI AREA
PIPELIFE INTERNATIONAL, a 50/50 joint venture between SOLVAY (Belgium) and WIENERBERGER (Austria), signed an agreement for the creation of a new plastic pipe company with a Chinese partner, Changzhou Reinforced Plastics Factory (CRPF). [EN]-[FR]-[NL]
August 16, 2000
EIGHT FOUNDERS SIGN DEFINITIVE AGREEMENT TO INCORPORATE ELEMICA
NEW YORK-August 16, 2000-The eight founding participants of Elemica announced today that they have signed a definitive agreement that formally creates the premier neutral, independent and secure e-marketplace for the chemical industry. [EN]
August 03, 2000
SOLVAY SODI TAKES CONTROL OF THREE BULGARIAN SUPPLIERS
The Bulgarian company Solvay Sodi AD, of which Solvay is one of the main shareholders, has acquired majority interests in the capital of three of its strategic suppliers. [EN]-[FR]-[NL]
August 02, 2000
INERGY AUTOMOTIVE SYSTEMS TAKES OVER NISSAN'S PLASTIC FUEL SYSTEMS ACTIVITIES AND STARTS AUTOMOTIVE PARTS PRODUCTION IN JAPAN
Tokyo - Solvay Automotive Asia KK, an affiliate of INERGY AUTOMOTIVE SYSTEMS, the joint company created by SOLVAY and PLASTIC OMNIUM which will be operational in September 2000, announces the signature, on July 31, 2000, of an agreement to acquire the plastic fuel systems production assets of Nissan Motor Co., Ltd. in Japan. [EN]-[FR]-[NL]
July 26, 2000
SOLVAY GROWS FURTHER IN FLUORINATED SPECIALITIES CAPACITY FOR REFRIGERANT TO BE EXPANDED
Solvay Fluor intends to more than double its current production capacity for Solkane® 134a, a hydrofluorocarbon which has no ozone depletion potential whatsoever and is used principally as a refrigerant. [EN]-[FR]-[NL]
July 17, 2000
INERGY AUTOMOTIVE SYSTEMS: Birth of a world leader in fuel systems
Following the approval by the European Commission, SOLVAY S.A. and PLASTIC OMNIUM have just received the go-ahead from the United States Federal Trade Commission to create a joint 50/50 owned company in the automotive fuel systems sector. [EN]-[FR]-[NL]
June 28, 2000
ELTEX®TUX100: A new high-performance cross-linkable ready-to-use hdpe compound for piping systems
In the late 1980's, Solvay Polyolefins Europe was the first HDPE producer in the world to launch the new generation PE100 material for gas and water pressure pipelines. [EN]-[FR]-[NL]
June 08, 2000
Opening Automated Molecular Assembly Plant Solvay Pharmaceuticals Weesp
On Tuesday, June 13, 2000, 10.00 a.m., Drs. E.A.A.M. Koopmans, Chief Executive Officer of Solvay Pharmaceuticals B.V. officially opens a new and innovative automated combinatorial chemistry production unit at the premises of Solvay Pharmaceuticals B.V. in Weesp, The Netherlands. [EN]-[FR]-[NL]
May 19, 2000
SOLVAY and PLASTIC OMNIUM take further step toward bringing together their Automotive Fuel Systems operations
Following the agreement in principle announced in January, SOLVAY S.A. and PLASTIC OMNIUM signed a shareholders agreement on May 19, 2000 creating a 50 /50-owned company which will combine their Automotive Fuel Systems operations worldwide. [EN]-[FR]-[NL]
May 03, 2000
PIPELIFE INTERNATIONAL BUYS JET STREAM PLASTIC PIPE Co. FROM WINROCK ENTERPRISES Inc.
PIPELIFE, THE JOINT VENTURE BETWEEN SOLVAY AND WIENERBERGER, LAYS THE FOUNDATIONS OF ITS DEVELOPMENT IN THE US.
[EN]-[FR]-[NL]
March 13, 2000
SOLVAY GROUP SELLS BRAZILIAN SUBSIDIARY CBCC TO DOW CORNING CORP
The SOLVAY GROUP is selling its Brazilian subsidiary COMPANHIA BRASILEIRA CARBURETO DE CALCIO (CBCC) to DOW CORNING Corp. (US). [EN]-[FR]-[NL]
February 29, 2000
SOLVAY Group : approval by U.S. FDA for AndroGelTM, First Gel to Treat Male Testosterone Deficiency
The Solvay Group today announced that its wholly owned subsidiary, Unimed Pharmaceuticals, Inc. obtained approval by the U.S. Food and Drug Administration (FDA) for AndroGelTM 1% (testosterone gel) (C-III). [EN]-[FR]-[NL]
February 14, 2000
UNITED STATES : SOLVAY ENGINEERED POLYMERS INNOVATES
Development of a mold-in-color metallic engineered polyolefin for plastic bumpers and external trim components
[EN]-[FR]-[NL]
February 09, 2000
SOLVAY GROUP PRELIMINARY 1999 RESULTS
Net earnings before extraordinary items of 423 million EUR, up 12%
16% increase in current net earnings per share
Cash flow sets new record, investments increase more than 40% in 1999. [EN]-[FR]-[NL]
February 07, 2000
SOLVAY STRENGTHENS ITS POSITION IN THE FIELD OF RESINS FOR HIGH-DENSITY POLYETHYLENE PIPES
The SOLVAY Group, through its subsidiary SOLVAY POLYOLEFINS EUROPE (SPE), has acquired 80 % of the shares of the Italian company PADANAPLAST SpA, located at Roccabianca, near Parma. [EN]-[FR]-[NL]
January 17, 2000
India
Main shareholders of Duphar-Interfran Ltd. jointly announce restructuring plans - Set up of a new company: Solvay Pharma India Ltd.
[EN]-[FR]-[NL]
January 13, 2000
PLASTIC OMNIUM and SOLVAY consider bringing together their Automotive Fuel Systems operations and sign an agreement in principle
PLASTIC OMNIUM and SOLVAY S.A have signed an agreement in principle to combine their Automotive Fuel Systems operations within a new equally (50-50)-shared company. [EN]
January 10, 2000
SOLVAY FLUOR BUSINESS : ACQUISITIONS IN USA AND MEXICO
Solvay intends to acquire Norfluor S.A. and Chemtech Products Inc. to strengthen its Fluor business in the Nafta market. [EN]-[FR]-[NL]
December 23, 1999
SOLVIN AND ELF ATOCHEM CONFIRM THE ACQUISITION OF VCM AND PVC PRODUCTION OF SHELL IN FRANCE
SOLVAY GROUP and ELF ATOCHEM made an offer on October 1, 1999 to SHELL CHEMICALS Ltd towards the acquisition of the vinyl chloride monomer (VCM) and PVC production activities of Shell in France. [EN]-[FR]-[NL]
December 22, 1999
THE SOLVAY GROUP REINFORCES ITS PRESENCE IN CENTRAL EUROPE: SOLVAY AND PANNONPLAST CREATE A JOINT VENTURE PANNON ALDRA, INDUSTRIAL SHEETS MANUFACTURER IN HUNGARY
SOLVAY (Belgium), through its French subsidiary ALKOR DRAKA S.A., and PANNONPLAST (Hungary) have signed an agreement towards the creation of a new company for the production and sale of calendered industrial sheets. [EN]-[FR]-[NL]
December 16, 1999
SOLVAY GROUP REINFORCES ITS POSITION IN PIPES AND FITTINGS IN TURKEY
SOLVAY (Belgium) and WIENERBERGER (Austria) announce the acquisition through the PIPELIFE Group (a 50/50 joint venture between the two companies) of all the shares of ARILI, a Turkish company with sales amounting to about EUR 15 million. [EN]-[FR]-[NL]
December 16, 1999
SOLVAY GROUP - INTERIM DIVIDEND
Solvay S.A's. Board of Directors decided at their meeting on December 16, 1999 to distribute on January 13, 2000 an unchanged net interim dividend of EUR 0.25 per share. [EN]-[FR]-[NL]
December 10, 1999
SOLVAY AND EVC HAVE SIGNED AN AGREEMENT TOWARDS THE ACQUISITION BY SOLVAY OF EVC'S PVC COMPOUNDS ACTIVITIES IN SPAIN
The SOLVAY Group (Brussels) and EVC International N.V. (Amsterdam) announce today that they have signed an agreement towards the acquisition by the SOLVAY Group of EVC Ibérica S.A., a Spanish EVC subsidiary specialized in the manufacturing of compounds. [EN]-[FR]-[NL]
December 10, 1999
SOLVAY GROUP SETS UP INTERNATIONAL PURCHASING DEPARTMENT
The SOLVAY Group announces the setting up of an International Purchasing Department. [EN]-[FR]-[NL]
December 06, 1999
SOLVAY REINFORCES ITS POSITION IN AUTOMOTIVE IN GERMANY WITH THE CREATION OF "SOLVAY AUTOMOTIVE FUEL SYSTEMS DEUTSCHLAND GmbH"
The SOLVAY Group announces the creation of "SOLVAY AUTOMOTIVE FUEL SYSTEMS DEUTSCHLAND GmbH" in November 1999. [EN]-[FR]-[NL]
November 15, 1999
Following the successful launch of its new plant, Solvay has decided to increase its peptide production capacity.
In order to be able to respond to the growth and diversification in demand for peptides, Solvay has decided to increase the production capacity of its PEPTISYNTHA subsidiary by 50 %. [EN]-[FR]-[NL]
October 06, 1999
DURAMED PHARMACEUTICALS AND SOLVAY PHARMACEUTICALS ANNOUNCE ALLIANCE IN THE USA
CINCINNATI, OH and MARIETTA, GA (October 6, 1999) -- Duramed Pharmaceuticals, Inc. (Nasdaq:DRMD) and Solvay Pharmaceuticals, Inc. today announced an alliance to jointly promote in the US three of the companies' hormone products: Duramed Pharmaceuticals' CENESTIN? (synthetic conjugated estrogens, A) Tablets and Solvay Pharmaceuticals' ESTRATEST®/ESTRATEST® H.S. Tablets (esterified estrogens and methyltestosterone) and PROMETRIUM® (progesterone) Capsules. [EN]-[NL]
October 06, 1999
SOLVAY PURSUES ITS DEVELOPMENT IN AUTOMOTIVE IN ASIA WITH THE CREATION OF "SOLVAY AUTOMOTIVE (THAILAND) Ltd", the first plastic fuel system business manufacturer in Thailand
The SOLVAY Group announces the creation of "SOLVAY AUTOMOTIVE (THAILAND) Ltd", a wholly owned subsidiary to be located in Rayong province, Thailand. The new company will produce and market plastic fuel systems and blow-moulded parts for the automotive industry. [EN]-[FR]-[NL]
October 01, 1999
SOLVAY AND ELF ATOCHEM INTEND TO ACQUIRE VCM AND PVC PRODUCTION ACTIVITIES OF SHELL IN FRANCE
SOLVAY GROUP and ELF ATOCHEM have made an offer to SHELL CHEMICALS Ltd towards the acquisition of the monomer Vinyl Chloride (VCM) and PVC production activities of Shell in France. [EN]-[FR]-[NL]
September 21, 1999
SOLVAY HAS BEEN ENTRUSTED BY THE EUROPEAN PVC PRODUCERS WITH CREATING AN INDUSTRIAL FACILITY PAVING THE WAY TO A NEW RECYCLING CHANNEL
The ECVM (European Council of Vinyl Manufacturers) choosed Solvay for the developement of a pilot plant designed to create a new channel for recycling used PVC. Solvay and the European PVC producers are hereby stressing their commitment to implement sustainable solutions to PVC recycling and improve the material's environmental performance throughout its life cycle. [EN]-[NL]
September 21, 1999
WATCO AND SOLVAY ARE JOINING FORCES TO BUILD RESOLEST, A FACILITY FOR RECYCLING RESIDUES FROM THE PURIFICATION OF DOMESTIC WASTE INCINERATOR FUMES.
SOLVAY and WATCO announce the set up a 50/50 joint venture called RESOLEUROPE S.A and their plan to build a RESOLEST platform, which will recycle residues from the purification of domestic waste incinerator fumes. [EN]-[FR]-[NL]
September 16, 1999
RECENT STRATEGIC DEVELOPMENTS OF SOLVAY IN ASIA
in Pipes and Fittings: acquisition by Pipelife Group of 100% of Wienerberger's PVC pipes activities in China. - in Barium and Strontium carbonates: control of Daehan Specialty Chemicals (DSC) in South Korea. - Other developments in Asia in 1999.
[EN]-[FR]-[NL]
September 10, 1999
STATEMENT ACCUSATIONS AGAINST SOLVAY INDUPA DO BRASIL REGARDING DIOXINS
The Elclor plant at Santo André (Solvay Indupa do Brasil) [EN]-[FR]-[NL]
September 07, 1999
SOLVAY GROUP ANNOUNCES AGREEMENT TO ACQUIRE ELLAY, INC. TO EXPAND GROUP'S PRESENCE IN U.S. MARKET FOR MEDICAL SUPPLY FILMS
Alkor Draka Advanced Films, Inc., a member of the Solvay Group of Brussels, Belgium, has entered into an agreement with Ellay, Inc. ("Ellay") to acquire all of the outstanding shares of the company, located in the city of Commerce (near Los Angeles), California. All existing activities of Alkor Draka Advanced Films, Inc. (located in LaPorte, Indiana) will be transferred to the Commerce, California location. [EN]-[NL]
August 30, 1999
PHILLIPS AND SOLVAY GROUP ANNOUNCE CONSTRUCTION OF SHARED U.S. HIGH-DENSITY POLYETHYLENE PLANTS
Initial plant capacity to be 700 million pounds (320,000 metric tons) per year. [EN]-[FR]-[NL]
July 29, 1999
SOLVAY GROUP RESULTS FOR THE FIRST HALF OF 1999
Net earnings and net earnings before extraordinary items of 182 million EUR: above the second half of 1998 and below the first half of 1998.
[EN]-[FR]-[NL]
July 27, 1999
COMMERCIAL START-UP ON AUGUST 1, 1999
SOLVAY (Belgium) and BASF (Germany) today announce the commercial start-up of their venture company, SOLVIN, on August 1, 1999. [EN]-[FR]-[NL]
July 20, 1999
SOLVAY PHARMACEUTICALS, INC. ACQUISITION OF UNIMED PHARMACEUTICALS, INC.
At midnight Monday, July 19, Solvay Pharmaceuticals acquired more than 95 percent of the shares of Unimed Pharmaceuticals. [EN]
July 06, 1999
SOLVAY ANNOUNCES FULL COMPLIANCE OF ITS VINYL CHLORIDE AND PVC PRODUCTION UNITS WITH THE ECVM CHARTER OBJECTIVES ESTABLISHED IN 1995 FOR SUSTAINABLE ENVIRONMENTAL PERFORMANCE
The environmental performances of the European production VCM - PVC units of Solvay located in Jemeppe and Antwerp (Belgium,) Tavaux (France), Rheinberg (Germany), and Martorell (Spain), were audited by the international bureau Det Norsk Veritas (DNV). All are shown to be 100% compliant with the targets agreed voluntarily four years ago in a pioneer Charter defining 12 emission standards for sustainable environmental protection. [EN]-[NL]
June 14, 1999
SOLVAY GROUP ANNOUNCES AGREEMENT TO ACQUIRE UNIMED PHARMACEUTICALS, INC. TO STRENGHTEN ITS MARKETING PRESENCE AMONG U.S. PRIMARY CARE PHYSICIANS.
As part of the Solvay Group's strategy of growing faster in pharmaceuticals, Solvay Pharmaceuticals, Inc, has entered into an agreement with Unimed Pharmaceuticals, Inc. (Nasdaq: UMED) to acquire all outstanding Unimed shares. [EN]-[FR]-[NL]
June 10, 1999
INAUGURATION OF THE SOLVAY CHAIR FOR TECHNOLOGICAL INNOVATION AT THE SOLVAY SCHOOL OF COMMERCE OF ULB AND AT INSEAD.
The Solvay Chair for Technological Innovation, offered by the Solvay Group jointly to the Solvay School of Commerce (ULB) and to INSEAD, was inaugurated today in the presence of 300 people in the premises of the ULB (Free University of Brussels). [EN]-[FR]-[NL]
May 27, 1999
CAPA® POLYCAPROLACTONES: NEW BIODEGRADABLE THERMOPLASTIC POLYMERS FROM SOLVAY
The Research and Development teams of the Solvay Group in Brussels have developed a new thermoplastic product based on Solvay's CAPA® polycaprolactone. [EN]-[FR]-[NL]
May 11, 1999
SOLVAY ACQUIRES TEVETEN®, AN INNOVATIVE CARDIOVASCULAR DRUG, FOR WORLD-WIDE MARKETING
Solvay announces today that it is acquiring Teveten®, a new oral antihypertensive from SmithKline Beecham for world-wide marketing, manufacturing and further development. [EN]-[FR]-[NL]
May 06, 1999
SOLVAY (BELGIUM) AND SUBANSAMBLE (ROMANIA) DECIDE TO CREATE A JOINT VENTURE, SOLVAY AUTOMOTIVE ROMANIA, IN THE FIELD OF PLASTIC FUEL SYSTEMS FOR THE AUTOMOTIVE INDUSTRY.
The SOLVAY Group (Belgium) and SUBANSAMBLE (Romania) have signed an agreement for the creation of a joint venture in Romania, SOLVAY AUTOMOTIVE ROMANIA. [EN]-[FR]-[NL]
May 05, 1999
ABOUT LUVOX® TABLETS
LUVOX® Tablets was the first medication approved by the Food and Drug Administration in the USA for Obsessive Compulsive Disorder (OCD) in children and adolescents. LUVOX® Tablets is safe and effective and is the medication most often prescribed by psychiatrists to treat this illness. [EN]
May 05, 1999
SOLVAY PHARMACEUTICALS, INC. ENTERS CARDIOVASCULAR MARKET Acquires U.S. Rights to ACEON® (perindopril erbumine) Tablets for Hypertension
Solvay Pharmaceuticals, Inc., today announced its entry into the U.S. cardiovascular market with ACEON® (perindopril erbumine) Tablets. [EN]-[FR]-[NL]
April 26, 1999
SOLVAY INTENDS TO CLOSE DOWN ITS ELECTROLYSIS UNIT AND PRODUCTION OF CHLORINATED DERIVATIVES AT ROERMOND SITE (NETHERLANDS)
This morning the Solvay Group informed the representatives of the related personnel of its intention to close by the end of the year the electrolysis unit and the production of chlorinated derivatives at its Roermond (Linne-Herten) site in The Netherlands. [EN]-[FR]-[NL]
April 22, 1999
AN INNOVATION OF THE SOLVAY GROUP: VINYLOOP® ALLOWS RECYCLING PVC COMPOUND PRODUCTS
The process is quite simple in its principle yet applying a high technology. [EN]-[FR]-[NL]
April 07, 1999
SOLVAY GROUP: LUVOX® AND DEPROMEL®, FIRST INNOVATIVE MENTAL HEALTH DRUG (SSRI), APPROVED FOR JAPANESE MARKET
On the 7th April 1999 the Japanese Ministry of Health and Welfare approved Luvox® and Depromel® (both brand names contain the active ingredient: fluvoxamine) for marketing in Japan. [EN]-[FR]-[NL]
March 30, 1999
SOLVAY GROUP - 1998 RESULTS
Net income before extraordinary items of 377 million EUR, up 15% - Net dividend of 1.55 EUR
[EN]-[FR]
March 26, 1999
SOLVAY GROUP : restructuring and reorganization of the salt production at Borth (Germany)
Owing to a very tough competition in the salt market, the Solvay Group intends to restructure the salt production on its site at Borth (Germany). [EN]-[FR]
March 19, 1999
SOLVAY REINFORCES ITS PRECIPITATED CALCIUM CARBONATE ACTIVITIES (PCC) BY ACQUIRING WINNOFIL® FROM ZENECA
Zeneca (UK) and Solvay (Belgium) announce that they have signed final agreement for the acquisition by Solvay of Zeneca's Winnofil® business (Precipitated Calcium Carbonate). [EN]-[FR]
March 08, 1999
SOLVAY AND BASF PURSUE DISCUSSIONS ON THEIR VINYLS VENTURE COMPANY SOLVIN, including : - Rationalization of their respective EDC- VCM - PVC units in Antwerp (Belgium) - Debottleneckings of existing VCM and PVC capacities
SOLVAY and BASF announced on October 2, 1998 the signature of a letter of intent towards the creation of a venture company for their European Polyvinyl Chloride (PVC) business (Spain excluded). [EN]-[FR]
February 11, 1999
SOLVAY GROUP - PRELIMINARY 1998 RESULTS
1998 : net earnings before extraordinary items of 377 million EUR, up 15% from 1997 Cash flow at record level. [EN]
February 10, 1999
SOLVAY AND SHANGHAI CHLOR ALKALI CHEMICAL INTEND TO CREATE A JOINT VENTURE TO DEVELOP PVC BLENDS AND COMPOUNDS IN CHINA
SOLVAY and SHANGHAI CHLOR ALKALI CHEMICAL (SCAC) will study the establishment of a Joint Venture for the production and sales of PVC compounds in China. [EN]-[FR]
February 09, 1999
SOLVAY AND ELF ATOCHEM TO REORGANIZE THEIR PVC PRODUCTION IN SPAIN
SOLVAY (Belgium) and ELF ATOCHEM (France) announce their intention to conclude an industrial cooperation agreement for PVC production in Spain. [EN]-[FR]
January 04, 1999
CONCLUSION OF THE SALE BY SOLVAY OF ITS WALLPAPERS ACTIVITIES TO THE GERMAN LPW GROUP
The SOLVAY Group and the LPW Group (LANGBEIN PFANHAUSER WERKE AG) announce that they have finalized the sale to the LPW Group of SOLVAY's wallpapers activities. [EN]-[FR]
December 21, 1998
U. S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVES PROMETRIUM® CAPSULES FOR HORMONE REPLACEMENT THERAPY
SOLVAY PHARMACEUTICALS, Inc.(USA) announces that the FDA has granted the approval to market in the USA the first oral micronized progesterone - PROMETRIUM® (progesterone, USP) Capsules - for use in Hormone Replacement Therapy (HRT). [EN]
December 17, 1998
SOLVAY GROUP STRENGTHENS ITS POSITION IN THE FIELD OF BARIUM AND STRONTIUM CARBONATES PRODUCTION AND MARKETING
The SOLVAY Group (Belgium) is one of the main producers in the Barium and Strontium carbonates business, with production sites in Hönningen (Germany), Massa (Italy), Monterrey (Mexico) and Onsan (South Korea). [EN]
December 14, 1998
SOLVAY GROUP - INTERIM DIVIDEND
Solvay S.A's. Board of Directors decided at their meeting on December 14, 1998 to distribute on January 14, 1999 an unchanged net interim dividend of BEF 10 per share. [EN]
December 01, 1998
PIPELIFE GROUP SIGNS PURCHASE AGREEMENT TO ACQUIRE THE NORWEGIAN MABO GROUP
Today, NORSK HYDRO, SOLVAY and WIENERBERGER have signed the purchase agreement for the acquisition by PIPELIFE of 100 % of the MABO GROUP, fully owned by the Norwegian company Norsk Hydro since 1993. [EN]
November 30, 1998
TODAY, NOVEMBER 30, 1998, OPENING OF A NEW DENSE SODA ASH PRODUCTION LINE AT THE SOLVAY SODI PLANT AT DEVNYA, BULGARIA
Today, November 30, 1998, the Belgian Prime Minister, Mr. Jean-Luc Dehaene and the Bulgarian Prime Minister, Mr. Ivan Kostov have paid a visit to the Solvay Sodi soda ash plant at Devnya, (close to Varna, Bulgaria), where they opened a new dense soda ash production line with a capacity of 400,000 tons/year. [EN]
November 18, 1998
SOLVAY INTENDS TO SELL ITS WALLPAPERS ACTIVITIES TO THE GERMAN LPW GROUP
The SOLVAY Group intends to sell its wallpapers activities to the German Group LANGBEIN PFANHAUSER WERKE AG (hereafter named LPW), whose majority shareholder is MICHAEL SCHROËR. [EN]
October 02, 1998
SOLVAY INTENDS TO STOP PVC PRODUCTION IN FERRARA (ITALY)
The SOLVAY group intends to close its polyvinyl chloride (PVC) production unit in Ferrara (Northern Italy) as from January 1, 1999, in line with its strategy to increase competitiveness of its European PVC activities. [EN]
October 02, 1998
SOLVAY AND BASF INTEND TO CREATE A JOINT VENTURE FOR THEIR VINYLS ACTIVITIES Important synergies expected in raw material supplies and economies of scale
The Belgian SOLVAY Group and the German BASF Group intend to create a joint venture for their European Polyvinyl Chloride (PVC) and worldwide Polyvinylidene Chloride (PVDC) businesses. [EN]
October 01, 1998
BELGIUM: FINA AND SOLVAY ANNOUNCE POLYETHYLENE CO-OPERATION AGREEMENTS
PetroFina S.A. (FINA) and SOLVAY have concluded two co-operation agreements in the area of high density polyethylene (HDPE), the first one being industrial and the second one being technological. [EN]
September 28, 1998
Continued Expansion of SOLVAY'S AUTOMOTIVE Activities: CREATION OF "SOLVAY AUTOMOTIVE POLSKA" (Poland)
The SOLVAY Group is setting up a wholly owned subsidiary in order to develop its automotive activities in Poland. [EN]
September 21, 1998
SOLVAY ENTERS ASIAN CAR MARKET WITH THE CREATION OF "SOLVAY AUTOMOTIVE ASIA K.K." IN JAPAN
The SOLVAY Group announces the creation of "SOLVAY AUTOMOTIVE ASIA K.K.", a wholly owned subsidiary to be located in Tokyo, Japan. [EN]
July 30, 1998
SOLVAY GROUP RESULTS FOR FIRST HALF 1998
NET EARNINGS AND NET EARNINGS BEFORE EXTRAORDINARY ITEMS OF BEF 8.3 BILLION
An increase of 36% compared to the first six months of 1997
NET EARNINGS BEFORE EXTRAORDINARY ITEMS OF 97 BEF PER SHARE... [EN]
July 17, 1998
PLASTIC OMNIUM AND SOLVAY JOIN FORCES IN BRAZIL. CREATION OF 'PLASTAUTO Ltda', AN AUTOMOTIVE JOINT VENTURE
PLASTIC OMNIUM and the SOLVAY Group today announce the creation in Brazil of a 50-50 joint venture for the production and marketing of fuel intake systems, consisting of plastic fuel tanks and filling tubes. [EN]
May 18, 1998
SOLVAY CONTRIBUTES TO CREATION OF EUROPEAN BANKING GROUP AROUND GENERALE DE BANQUE AND FORTIS
The 'Mutuelle SOLVAY', a subsidiary to the SOLVAY Group, has decided to transfer to FORTIS A.G. all its GENERALE DE BANQUE shares in exchange for new FORTIS A.G. shares. The exchange ratio has been fixed at 3 GENERALE DE BANQUE shares against 7 new FORTIS shares. [EN]
May 05, 1998
AIR PRODUCTS completes purchase of SOLVAY'S SOLKATRONIC Chemicals
Air Products and Chemicals, Inc. (NYSE: APD) and the Solvay Group announce today that Air Products has completed its purchase of SOLKATRONIC Chemicals, Inc., a leading manufacturer of ultra-high purity gases, chemicals and gas handling equipment from Solvay America Inc. Late last year, the two companies had signed a letter of intent to that effect. [EN]
May 04, 1998
SOLVAY WINS 'BEST INVESTOR OF THE YEAR' IN BULGARIA
The SOLVAY Group is proud to have been chosen as Best Foreign Investor of the Year 1997 by the Foreign Investment Agency of the Republic of Bulgaria. [EN]
April 21, 1998
Solvay's "Alkor GmbH Kunststoffe" to cooperate with U.S. and Japanese partners GLOBAL ALLIANCE TO DEVELOP BUSINESS OF INTERIOR TRIM MATERIALS TO CAR INDUSTRY
O'SULLIVAN Corporation, TATSUTA Chemical Corporation Ltd. and ALKOR GmbH Kunststoffe have decided to form a global alliance for cooperation in design, development and manufacture of automotive trim materials. [EN]
April 14, 1998
SOLVAY PHARMACEUTICALS, INC. (USA) LAUNCHES MARKETING OF ESTRATAB® TABLETS FOR THE PREVENTION OF OSTEOPOROSIS.
One month after the American Food and Drug Administration gave its approval to market 0.3 mg ESTRATAB® (Esterified Estrogens Tablets, USP) for the prevention of osteoporosis, Solvay Pharmaceuticals, Inc. (Marietta, Ga., USA) now effectively launches the marketing in the United States of the low oral estrogen dose of ESTRATAB® Tablets for this new indication. [EN]
April 08, 1998
SOLVAY GROUP - FINAL 1997 RESULTS
NET INCOME BEFORE EXTRAORDINARY ITEMS OF BEF 13.2 BILLION, UP 15%, INCREASE IN NET DIVIDEND FROM BEF 55 TO BEF 60 PER SHARE. [EN]
March 05, 1998
SOLVAY AND LUMMUS JOIN FORCES TO PROMOTE SOLVAY'S VCM AND PVC TECHNOLOGIES
The Solvay Group and ABB Lummus Global have announced a cooperation agreement to promote and license SOLVAY's vinyl chloride monomer (VCM) and suspension polyvinyl chloride (PVC) manufacturing technologies. [EN]
February 05, 1998
SOLVAY GROUP - PRELIMINARY 1997 RESULTS
The Solvay Group closed 1997 with net earnings before extraordinary items of BEF 13.2 billion, a 15 % increase compared to the BEF 11.5 billion recorded in 1996. The improvement was seen particularly in the second half of the year...
[EN]
January 29, 1998
JOINT VENTURE WITH US-COMPANY 'DYNEON' FOR VF2-MONOMER PRODUCTION AND NEW PVDF SOLEF ® -PLANT IN DECATUR (Alabama, USA)
SOLVAY ADVANCED POLYMERS, Inc. (SAPI), a subsidiary of Solvay America, Inc. and DYNEON LLC, announced today that they have formed a joint venture to build and operate a plant to produce vinylidene fluoride monomer (VF2). [EN]
January 27, 1998
SOLVAY and the 1998 Football World Cup: KEY-ROLE OF PVC IN DESIGN AND CONSTRUCTION OF 'LE STADE DE FRANCE'
Solvay and PVC (Polyvinyl Chloride) both have been key-players in the design and construction of 'Le Stade de France', the magnificent new landmark stadium built for the 1998 World Cup near Paris, with a capacity of 80,000, which will be inaugurated on January 28. [EN]
January 22, 1998
SOLVAY PHARMACEUTICALS: NEW ORGANIZATIONS IN SCANDINAVIA AND GREECE REFLECT DETERMINATION TO STRENGTHEN HEALTHCARE ACTIVITIES
As from January 1st, SOLVAY PHARMACEUTICALS has set up a wholly owned subsidiary in Greece, named SOLVAY PHARMA M.E.P.E. The newly formed company will deal with imports, local manufacturing, marketing and distribution of the Group's pharmaceutical products and has taken over the activities of SOLVAY PHARMA Hellas, which was mostly a marketing unit. [EN]
January 05, 1998
SOLVAY PHARMACEUTICALS, INC. ACQUIRES U.S. MARKETING RIGHTS TO PROMETRIUM® NATURAL MICRONIZED PROGESTERONE
Marietta, GA, (January 5th, 1998) -- Solvay Pharmaceuticals, Inc. announced today that it will add the natural progesterone, PROMETRIUM® (progesterone, USP) Capsules 100 mg to its expanding portfolio of women's health products. The acquisition from Schering-Plough Corp. marks the third women's health product licensed or acquired by Solvay Pharmaceuticals since June 1997. [EN]
December 23, 1997
INDUPA, LEADING ARGENTINEAN CAUSTIC SODA AND PVC PRODUCER, DECIDES THE ACQUISITION OF SIMILAR ACTIVITIES FROM SOLVAY DO BRASIL
The Board of Directors of INDUPA S.A.I.C. (Buenos Aires, Argentina) has expressed in October 1997, its intention of reinforcing the positioning of the company's products (PVC and caustic soda) within Mercosur, by acquiring similar activities in Brazil if possible. [EN]
December 15, 1997
SOLVAY GROUP - INTERIM DIVIDEND
Solvay S.A's. Board of Directors have decided at their meeting on December 15, 1997 to distribute on January 12, 1998, a net interim dividend of BEF 10 per share, taking into account the 10 for one split of Solvay shares in August 1997. [EN]
November 20, 1997
SOLVAY INTEROX TO CLOSE RESEARCH SITE AT WIDNES (U.K.).
Solvay Interox Ltd has decided to close down its Research Site in Widnes (United Kingdom) by mid or late 1998. [EN]
November 17, 1997
BIOTECH ALLIANCE SIGNED BETWEEN SOLVAY AND INNOGENETICS IN GENOMIC RESEARCH. SOLVAY takes an equity stake into INNOGENETICS.
Solvay (Brussels, Belgium) and INNOGENETICS (Ghent, Belgium) jointly announced today that they have entered into an agreement in molecular biology focusing on the discovery of novel genes encoding potential drug targets expected to be involved in human disease processes. [EN]
November 06, 1997
SOLVAY AMERICA TO SELL SOLKATRONIC CHEMICALS TO AIR PRODUCTS.
SOLVAY AMERICA, Inc. and AIR PRODUCTS & CHEMICALS, Inc. have signed a letter of intent for the sale of SOLKATRONIC CHEMICALS, Inc. to AIR PRODUCTS. The two companies expect the transaction to be finalized within three months, pending receipt of all necessary board approvals and regulatory clearances. [EN]
October 28, 1997
INDUPA, LEADING ARGENTINIAN CAUSTIC SODA AND PVC PRODUCER, STUDIES INTEREST OF ACQUIRING SIMILAR ACTIVITIES FROM SOLVAY DO BRASIL.
INDUPA's Board of Directors considers strengthening the positioning of its products within Mercosur by the possible acquisition of similar activities in Brazil. [EN]
October 16, 1997
SOLVAY PHARMACEUTICALS ACQUIRES MARKETING RIGHTS FOR INNOVATIVE COMBINATION HORMONE REPLACEMENT PATCH FROM MERCK.
SOLVAY PHARMACEUTICALS Inc, based in Marietta (Georgia, USA) has acquired from MERCK KGaA of Darmstadt (Germany) licensing rights for the USA and Canada for a combination hormone replacement therapy (HRT) matrix patch. [EN]
October 15, 1997
PIPELIFE GROUP SIGNS LETTER OF INTENT TO ACQUIRE THE SWEDISH PVC-PIPE MANUFACTURER DAVINYL A.B.
EVC International N.V., SOLVAY S.A. and WIENERBERGER Rohrsysteme und Abwassertechnik GmbH, have signed a letter of intent towards the acquisition by the PIPELIFE Group of all shares of DAVINYL AB, a Swedish subsidiary of EVC. [EN]
October 01, 1997
SOLVAY INTENDS TO SELL OFF ITS PLASTIC COATING ACTIVITIES TO MECASEAT
The MECASEAT and SOLVAY groups are negotiating an agreement on the acquisition by MECASEAT of SOLVAY's subsidiaries GRIFFINE ENDUCTION (Nucourt, France) and GORVI (Pamplona, Spain) . [EN]
September 16, 1997
SOLVAY EXPANDS POSITION AS LEADING PVC PRODUCER IN MERCOSUR
Both INDUPA, the leading Argentinian PVC and caustic soda producer -owned 51 % by the SOLVAY Group- and SOLVAY do BRASIL, another leading PVC producer in the region, announce significant capacity expansions. [EN]
September 03, 1997
SOLVAY SELLS ITS SHARE IN CRYSTEX ® BUSINESS TO ITS PARTNER FLEXSYS
The SOLVAY and FLEXSYS groups have reached an agreement whereby FLEXSYS will acquire SOLVAY's 50 per cent share of their joint venture 'Kali Chemie Akzo GmbH (KCA)'. [EN]
August 26, 1997
SOLVAY OPENS SALES REPRESENTATION OFFICE IN MOSCOW (RUSSIA)
In line with the progressive development of its activities in the countries of Central and Eastern Europe, the SOLVAY Group is opening a sales representation office in Moscow by the end of this month. [EN]
July 31, 1997
SOLVAY GROUP RESULTS FOR THE FIRST SIX MONTHS OF 1997
Net profit of BEF 6.1 billion 3 % increase in net earnings before extraordinary items compared to the first half of 1996. [EN]
July 31, 1997
THE CHAIRMANSHIP OF THE BOARD AND OF THE EXECUTIVE COMMITTEE OF SOLVAY FROM JUNE 4, 1998
On June 1998, immediately after the General Meeting of Shareholders, Mr Yves Boël, having reached the age of seventy, will retire as Chairman and as a member of the Solvay Board of Directors. [EN]
July 16, 1997
SOLVAY INVESTS IN NAMIBIA : Acquisition of fluorspar mine in support of Group's growing fluorine activities
The SOLVAY Group has decided to acquire the fluorspar mine at Okorusu in Namibia (Southern Africa). [EN]
June 26, 1997
SOLVAY CONTINUES EXPANSION IN DENSE SODA ASH After Solvay Sodi (Bulgaria), a new investment in Bernburg (Germany) !
The SOLVAY Group has decided to extend the dense soda ash (or sodium carbonate) capacity of its plant in Bernburg (near Leipzig), Germany, by building a second densification line. [EN]
June 15, 1997
SOLVAY SODI: IN THE INTEREST OF ALL SHAREHOLDERS NEWLY ELECTED BOARD OF DIRECTORS DECIDES 40 BILLION LEVA (25 MILLION USD) INVESTMENT FOR SODA ASH PLANT AT DEVNYA (BULGARIA)
On June 13, 1997, the newly elected Board of Directors of SOLVAY SODI JSCO, meeting in Sofia, decided to invest 40 billion Leva (about 25 million USD) in its soda ash plant at Devnya (near the Bulgarian town of Varna). [EN]
June 03, 1997
SOLVAY GROUP : CONTINUED EXPANSION IN MERCOSUR WITH USD 66 MILLION INVESTMENT IN INDUPA PLANT AT BAHIA BLANCA (ARGENTINA)
INDUPA S.A., the leading Argentinian caustic soda and PVC manufacturer, controlled 51 % by the SOLVAY Group, is investing USD 66 million (BEF 2. 3 billion) for the expansion of the electrolytic and the VCM units in its industrial complex at Bahia Blanca (Argentina). [EN]
June 02, 1997
CFF'S BOWL FOR BREATH GAINS FIRST NATIONAL SPONSOR
The Cystic Fibrosis Foundation (CFF) is adding a new team player to its annual Bowl for Breath event: Solvay Pharmaceuticals, Inc. [EN]
May 26, 1997
SOLVAY GROUP GRANTS FUJISAWA THE DISTRIBUTION RIGHTS OF LUVOXTM IN JAPAN
The SOLVAY Group and FUJISAWA Pharmaceutical Co. entered into a distribution agreement for LUVOXTM (fluvoxamine) in Japan. [EN]
May 13, 1997
LUVOX® (Fluvoxamine Maleate) TABLETS OFFERS HOPE FOR OBSESSIVE COMPULSIVE DISORDER (OCD) IN CHILDREN AND ADOLESCENTS
MARIETTA, GA, March 25, 1997 -- LUVOX® (fluvoxamine maleate) Tablets is the first SSRI to gain clearance from the U.S. Food and Drug Administration (FDA) to treat Obsessive Compulsive Disorder (OCD) [http://www.ocdresource.com] in children and adolescents. [EN]
April 15, 1997
SOLVAY GROUP FINALISES DEAL WITH BULGARIAN AUTHORITIES ON THE ACQUISITION OF SODI DEVNYA
The Government of BULGARIA, the Bulgarian Privatisation Agency and the SOLVAY Group finalized the transfer to SOLVAY of 60 % of the shares of "SODI", the major soda ash producing plant located at Devnya, near Varna. [EN]
April 08, 1997
SOLVAY GROUP STRENGTHENS POSITION AS IMPORTANT AUTOMOTIVE SUPPLIER
ACQUISITION BY SOLVAY AMERICA OF DEXTER's SHARE IN D&S PLASTICS INTERNATIONAL [EN]
March 27, 1997
SOLVAY GROUP - FINAL RESULTS FOR 1996
The Solvay Group confirms the preliminary earnings figures announced on February 6, 1997. [EN]
March 05, 1997
SOLVAY AND IBM GROUPS JOIN SKILLS BY CREATING A JOINT VENTURE FOR THE MANAGEMENT OF SOLVAY'S MAINFRAME AND UNIX SYSTEMS IN EUROPE
The SOLVAY Group (Brussels, Belgium) and IBM Belgium S.A. on March 4, 1997 signed a letter of intent towards the creation of a joint venture which will ensure management of SOLVAY's IBM mainframe and UNIX systems in Europe. [EN]
February 28, 1997
SOLVAY GROUP CLOSES THE SALE OF ITS ANIMAL HEALTH ACTIVITIES TO AMERICAN HOME PRODUCTS CORPORATION FINAL STEP
The SOLVAY Group today finalized with AMERICAN HOME PRODUCTS CORPORATION the closing of the sale of all of SOLVAY's Animal Health activities worldwide.
[EN]
February 06, 1997
SOLVAY GROUP - PRELIMINARY 1996 RESULTS
Following a second half marked by a slow improvement in plastics margins and an erosion of caustic soda prices, the Solvay Group anticipates that its 1996 consolidated net profit will be approximately 13.6 billion Belgian francs (BEF), compared to BEF 12.5 billion in 1995, an increase of 9 %. [EN]
February 05, 1997
SOLVAY do BRASIL SELLS ITS SUBSIDIARY ?PLASTICOS PLAVINIL? TO OCCIDENTAL QUIMICA
SOLVAY do BRASIL (Sao Paulo) will sell all shares of its subsidiary PLASTICOS PLAVINIL - a manufacturer of industrial sheets - to OCCIDENTAL QUIMICA do BRASIL (Rio de Janeiro). [EN]
February 05, 1997
SOLVAY GROUP TO CLOSE DOWN ITS ELECTROLYTIC UNIT AT HALLEIN (Austria)
The SOLVAY Group has decided to close down its Electrolytic Unit at Hallein (near Salzburg) in Austria by the end of this year. [EN]
January 29, 1997
SOLVAY INTEROX: NEW EUROPEAN FACILITY TO PRODUCE ULTRA HIGH PURITY HYDROGEN PEROXIDE FOR THE SEMICONDUCTOR INDUSTRY
SOLVAY Interox will build a new state of the art plant in Bernburg (Germany) to produce ultra high purity hydrogen peroxide (H2O2). [EN]
January 17, 1997
SOLVAY ACQUIRES NOKIA'S PARTICIPATION IN OY FINNISH PEROXIDES AB ("FINNPER")
The SOLVAY Group has increased its participation in OY FINNISH PEROXIDES AB ("FINNPER") from 50 % to a majority of 75 % . [EN]
December 19, 1996
SOLVAY SIGNS A PRELIMINARY AGREEMENT WITH BULGARIAN AUTHORITIES ON ACQUISITION OF 60 PERCENT OF SODI SHARES
The Privatisation Agency of the Republic of BULGARIA and the SOLVAY Group have signed a preliminary agreement which will allow SOLVAY to acquire sixty per cent of the shares of SODI S.P.J.S.Co., an important soda ash producer situated at Devnya, in proximity of the Black Sea town of Varna, at the price of USD 160 million (BEF 5.1 billion). [EN]
December 13, 1996
SOLVAY GROUP SETS UP SOLVAY POLYOLEFINS EUROPE"(SPE), A WHOLLY-OWNED SUBSIDIARY
The SOLVAY Group has set up a wholly owned subsidiary comprising its European polyolefin activities (high density polyethylene and polypropylene) which will be named SOLVAY POLYOLEFINS EUROPE (SPE) and will be operational by January 1, 1997. [EN]
December 12, 1996
SOLVAY GROUP - INTERIM DIVIDEND
Solvay S.A's. Board of Directors, have decided at their meeting on December 12, 1996, to distribute on January 23, 1997, a net interim dividend of BEF 100 per share.
[EN]
October 17, 1996
SOLVAY AUTOMOTIVE STRENGTHENS ITS COMPETITIVE POSITION WITH A NEW PRODUCTION FACILITY IN ADRIAN (Michigan, USA)
SOLVAY AUTOMOTIVE Inc. today celebrated the opening of its new facility in Adrian, (Michigan, USA) which will manufacture plastic fuel systems and composite intake manifolds for its Chrysler, Ford and General Motors customers. [EN]
September 20, 1996
AMERICAN HOME PRODUCTS INTENDS TO ACQUIRE ALL ANIMAL HEALTH ACTIVITIES FROM SOLVAY
The SOLVAY Group and AMERICAN HOME PRODUCTS Corporation intend to enter into an agreement for the sale of all SOLVAYs Animal Health activities worldwide to AMERICAN HOME PRODUCTS, for an approximate price of USD 450 million (BEF 14 billion) subject to audits, and final closing adjustments. [EN]
August 29, 1996
HUMAN HEALTH : SOLVAY GROUP : PROJECT TO SUBSTITUTE SOME EXISTING BORROWINGS
THE SOLVAY Group has reached an agreement with Deutsche Bank and Générale de Banque (as co-arrangers) on the principle of a bank commitment for an amount of DEM 1 billion for a 7 year period. [EN]
July 25, 1996
SOLVAY GROUP - RESULTS FOR THE FIRST SIX MONTHS OF 1996
After the slowdown in European demand and the drop in plastics prices which marked results in the second half of 1995, earnings over the first half of 1996 showed a clear improvement, with the SOLVAY Group's consolidated net earnings climbing to BEF 6.0 billion, compared to BEF 4.2 billion for the previous six months - an increase of 43%. These figures are down however, (-28%), compared to the BEF 8.3 billion of the first half of 1995, when the Plastics sector performed exceptionally well. [EN]
July 24, 1996
AIR LIQUIDE AND SOLVAY TO BUILD COGENERATION POWER STATION IN SPAIN
The SOLVAY and the AIR LIQUIDE Group have reached an agreement towards the construction of a cogeneration power station (supplying both steam and electricity) on the site of SOLVAY' soda ash plant at Torrelavega (Cantabria, Spain). [EN]
July 17, 1996
SOLVAY and the OLYMPIC GAMES - Atlanta 1996
Solvay S.A. is proud to contribute in several ways to the Atlanta Olympic Summer Games , which are about to start. [EN]
July 04, 1996
SOLVAY CREATES AUTOMOTIVE JOINT VENTURE IN ARGENTINA
The SOLVAY Group, based in Brussels (Belgium) and INDUSTRIAS MONTICH S.R.L., headquartered in Cordoba (Argentina), have decided to form a joint venture Company, which will manufacture plastic fuel tanks, filler pipes and other blow moulded and injected plastic parts for the Argentinian car industry. [EN]
July 01, 1996
SOLVAY GROUP SELLS ITS INDUSTRIAL ENZYMES BUSINESS TO GENENCOR
GENENCOR International, Inc., based in Rochester (NY) today has finalized its acquisition of the industrial enzymes business from the SOLVAY Group. [EN]
June 24, 1996
SOLVAY MINERALS EXPANDS SODA ASH IN WYOMING, USA TO 3.5 MILLION SHORT TONS/YEAR
In view of the continued expansion of worldwide soda ash demand principally in Asia and Latin America, and of the growing requirements of ASAHI for their flat glass production, SOLVAY announces that the SOLVAY Soda Ash Joint Venture in Green River, Wyoming intends to expand its trona mining and soda ash capacity to 3.5 million short tons per year. [EN]
June 17, 1996
SOLVAY GROUP AND O?SULLIVAN CORPORATION FORM STRATEGIC ALLIANCE FOR AUTOMOTIVE ACTIVITIES
The SOLVAY Group of Brussels, Belgium, and O'SULLIVAN Corporation (Winchester, USA) have formed a strategic alliance, the purpose of which is to ensure that the demands of their automotive customers for interior trim PVC basic applications are met worldwide in the most efficient way. [EN]
June 04, 1996
SOLVAY ACQUIRES HOECHST FLUOROCARBONS BUSINESS
Solvay S.A. and HOECHST AG yesterday in Frankfurt/Main finalised and signed an agreement, already announced on February 2, by which SOLVAY acquires most of HOECHST's fluorocarbons business. The transfer of the business is scheduled for June 30, 1996, provided the necessary autorisation of the relevant antitrust authorities is delivered in time. [EN]
May 23, 1996
SOLVAY ACQUIRES CANADIAN LACTULOSE MANUFACTURING FACILITY FOR ITS HUMAN HEALTH DIVISION
As of today, the SOLVAY-Group expands its Human Health Division, through the acquisition of CANLAC Corporation by SOLVAY KINGSWOOD Inc. (Toronto, Ontario, Canada). CANLAC, a lactulose liquid production plant is based at Victoriaville in Quebec, Canada. [EN]
May 13, 1996
SOLVAY : INVESTMENTS IN SODIUM BICARBONATE AND SODIUM CARBONATE IN EUROPE
Considering the growth of the European market for sodium bicarbonate and the successful development of the NEUTREC ® process for the treatment of flue gases, SOLVAY has decided to build a new sodium bicarbonate production line at Dombasle (France) of 45,000 tons a year and to expand its unit at Rosignano (Italy) from 80,000 to 100,000 tons a year. [EN]
April 02, 1996
SOLVAY GROUP - FINAL RESULTS FOR 1995
The year 1995 showed an important increase in net consolidated profits, which amounted to BEF 12.51 billion, whereas in 1994 they reached BEF 7.96 billion, i.e. a 57 % growth. [EN]
March 11, 1996
SOLVAY ACQUIRES MAJOR GERMAN AUTOMOTIVE SUPPLIER
The SOLVAY Group today strengthens its position as a supplier to the German automotive industry, as it signed an agreement towards the acquisition of HELPHOS GmbH, a specialized producer of technical parts for the automotive industry. The agreement comes into effect retroactively, from January 1st 1996 onwards. [EN]
February 09, 1996
SOLVAY : MAJOR EXPANSION IN SOUTH AMERICA ACQUISITION OF A MAJOR STAKE IN INDUPA?s CHEMICAL ACTIVITIES AT BAHIA BLANCA (ARGENTINA)
The SOLVAY Group made an offer for acquiring from DOW QUIMICA ARGENTINA S.A. and YPF S.A., the private Argentinian oil company, a majority stake in DERIVADOS PETROQUIMICOS DE INVERSION S.A., a holding company totally controlled by DOW and YPF, owner of a major shareholding in INDUPA S.A. [EN]
February 02, 1996
CFC SUBSTITUTES : SOLVAY INTENDS TO ACQUIRE THE HOECHST FLUOROCARBONS BUSINESS
SOLVAY and HOECHST have signed an agreement granting SOLVAY the exclusive right to acquire the HOECHST fluorocarbons business worldwide. [EN]
